From a7669b225c02a4ed1aec2bd80b0a49cafa2d0148 Mon Sep 17 00:00:00 2001
From: Beatrice Drago <bdrago@kb-bioinfo01.cancer.dk>
Date: Thu, 11 Dec 2025 19:34:26 +0100
Subject: [PATCH] Change format of PTM column for glycosylation #246

---
 cancermuts/datasources.py        |  30 +++++++++++++++++--
 cancermuts/properties.py         |  48 +++++++++++++++++--------------
 cancermuts/table.py              |   6 ++--
 docs/metatable.csv               |  26 ++++++++---------
 docs/metatable_non_canonical.csv |   2 +-
 docs/metatable_pancancer.csv     |  32 ++++++++++-----------
 docs/my_table.pdf                | Bin 25430 -> 25947 bytes
 docs/my_table_pancancer.pdf      | Bin 28170 -> 28684 bytes
 8 files changed, 87 insertions(+), 57 deletions(-)

diff --git a/cancermuts/datasources.py b/cancermuts/datasources.py
index 53a34f3e..b4b0d386 100644
--- a/cancermuts/datasources.py
+++ b/cancermuts/datasources.py
@@ -1846,12 +1846,12 @@ def __init__(self, database_dir, database_files=None):
         self._ptm_types = ['acetylation', 'methylation', 'O-GalNAc', 'O-GlcNAc', 'phosphorylation', 'sumoylation', 'ubiquitination']
         self._ptm_types_to_classes = {  'acetylation'     : 'ptm_acetylation',
                                         'methylation'     : 'ptm_methylation',
-                                        'O-GalNAc'        : 'ptm_ogalnac',
-                                        'O-GlcNAc'        : 'ptm_oglcnac',
+                                        'O-GalNAc'        : 'ptm_glycosylation',
+                                        'O-GlcNAc'        : 'ptm_glycosylation',
                                         'phosphorylation' : 'ptm_phosphorylation',
                                         'sumoylation'     : 'ptm_sumoylation',
                                         'ubiquitination'  : 'ptm_ubiquitination' }
-        self._ptm_suffixes = ['ac', 'm[0-9]', 'ga', 'gl', 'p', 'sm', 'ub']
+        self._ptm_suffixes = ['ac', 'm[0-9]', 'gly', 'gly', 'p', 'sm', 'ub']
         self._ptm_suffix_offsets = [-3, -3, -3, -3, -2, -3, -3]
 
         self._database_dir = database_dir
@@ -1931,6 +1931,30 @@ def add_position_properties(self, sequence, properties=None):
                                                         )
                     position.add_property(property_obj)
                     self.log.info("adding %s to site %s" % (m, property_obj.name))
+                
+                is_gly = False
+                has_gly_site = False
+                has_gly_sub = False
+                for prop in position.properties.values():
+                    if prop.category == 'ptm_glycosylation':
+                        is_gly = True
+                        break 
+                
+                has_gly_site = any(prop.category == 'ptm_glycosylation' for prop in position.properties.values())
+                if not has_gly_site:
+                    gly_site = position_properties_classes['ptm_glycosylation'](
+                        position=position,
+                        sources=[self])
+                    position.add_property(gly_site)
+
+                has_gly_subtype = any(prop.header == 'glycosylation_subtype' for prop in position.properties.values())
+                if not has_gly_subtype:
+                    gly_sub = position_properties_classes['glycosylation_subtype'](
+                        position=position,
+                        sources=[self],
+                        subtype=""     
+                    )
+                    position.add_property(gly_sub)
 
 class MyVariant(DynamicSource, object):
     @logger_init
diff --git a/cancermuts/properties.py b/cancermuts/properties.py
index 48050ee6..c3a92414 100644
--- a/cancermuts/properties.py
+++ b/cancermuts/properties.py
@@ -173,15 +173,15 @@ def __init__(self, position, sources):
 
     def get_value_str(self):
         return self.code
-
-class OGalNAcSite(PositionProperty):
-    description = "OGalNAc site"
-    header = "ogalnac_site"
-    category='ptm_ogalnac'
-    code = "O-GalNAc"
+    
+class GlycosylationSite(PositionProperty):
+    description = "Glycosylation site"
+    header = "glycosylation_site"
+    category='ptm_glycosylation'
+    code = "Gly"   
 
     def __init__(self, position, sources):
-        super(OGalNAcSite, self).__init__(  name="o-GalNAc Site",
+        super(GlycosylationSite, self).__init__(  name="Glycosylation Site",
                                                     position=position,
                                                     sources=sources,
                                                     values={},
@@ -189,31 +189,37 @@ def __init__(self, position, sources):
 
     def get_value_str(self):
         return self.code
+    
+class GlycosylationSubtype(PositionProperty):
+    description = "Glycosylation Subtype"
+    header = "glycosylation_subtype"
+    category="glycosylation_subtype"
+    #code =    
 
-class OGlcNAcSite(PositionProperty):
-    description = "OGlcNAc site"
-    header = "oglcnac_site"
-    category='ptm_oglcnac'
-    code = "O-GlcNAc"
-
+    subtype = ""
 
-    def __init__(self, position, sources):
-        super(OGlcNAcSite, self).__init__(  name="o-GlcNAc Site",
+    def __init__(self, position, sources, subtype):
+        super(GlycosylationSubtype, self).__init__(  name="GlycosylationSubtype",
                                                     position=position,
                                                     sources=sources,
-                                                    values={},
+                                                    values={"subtype": subtype},
                                                     metadata={}  )
 
     def get_value_str(self):
-        return self.code
-
+        return self.values.get("subtype", "")
+        #return self.values.get("subtype")
+        #val = self.values.get("subtype")
+        #if val is None:
+            #return ""
+        #else:
+            #return str(val)
+    
 class SumoylationSite(PositionProperty):
     description = "Sumoylation site"
     header = "sumoyylation_site"
     category='ptm_sumoylation'
     code = "Sumo"
 
-
     def __init__(self, position, sources):
         super(SumoylationSite, self).__init__(  name="Sumoylation Site",
                                                     position=position,
@@ -306,8 +312,8 @@ def __init__(self, position, sources):
                                  'ptm_methylation'                : MethylationSite,
                                  'ptm_acetylation'                : AcetylationSite,
 				                 'ptm_nitrosylation'              : SNitrosylationSite,
-                                 'ptm_ogalnac'                    : OGalNAcSite,
-                                 'ptm_oglcnac'                    : OGlcNAcSite,
+                                 'ptm_glycosylation'              : GlycosylationSite,
+                                 'glycosylation_subtype'          : GlycosylationSubtype,
                                  'ptm_sumoylation'                : SumoylationSite,
                                  'ptm_ubiquitination'             : UbiquitinationSite,
                                  'ptm_cleavage'                   : CleavageSite,
diff --git a/cancermuts/table.py b/cancermuts/table.py
index 0d0e2c13..7a19a559 100644
--- a/cancermuts/table.py
+++ b/cancermuts/table.py
@@ -125,8 +125,8 @@ class Table:
     ptm_colors = defaultdict(lambda: 'black',
                 {   'ptm_acetylation'     : 'grey',
                     'ptm_methylation'     : 'darkgreen',
-                    'ptm_ogalnac'         : 'orange',
-                    'ptm_oglcnac'          : 'darkorange',
+                    'ptm_glycosylation'   : 'orange',
+                    'ptm_gly_subtype'     : 'darkorange',
                     'ptm_phosphorylation' : 'red',
                     'ptm_ubiquitination'  : 'blue',
                     'ptm_sumoylation'     : 'lightblue',
@@ -181,7 +181,7 @@ def __init__(self, labels=None, ptm_colors=None, y_ptm=1.02):
     def to_dataframe(self, sequence, mutation_metadata=["cancer_study", "cancer_type", "genomic_coordinates", "genomic_mutations", "revel_score", "cancer_site", "cancer_histology",'gnomad_exome_allele_frequency', 'gnomad_genome_allele_frequency', 
                                                         'gnomad_popmax_exome_allele_frequency', 'gnomad_popmax_genome_allele_frequency', 'clinvar_variant_id', 'clinvar_germline_classification', 'clinvar_germline_condition', 'clinvar_germline_review_status', 
                                                         'clinvar_oncogenicity_classification', 'clinvar_oncogenicity_condition', 'clinvar_oncogenicity_review_status', 'clinvar_clinical_impact_classification', 'clinvar_clinical_impact_condition', 'clinvar_clinical_impact_review_status'],
-                        position_properties=['ptm_phosphorylation','ptm_methylation','ptm_ubiquitination','ptm_cleavage', 'ptm_nitrosylation','ptm_acetylation', 'ptm_sumoylation', 'ptm_ogalnac', 'ptm_oglcnac', 'mobidb_disorder_propensity'],
+                        position_properties=['ptm_phosphorylation','ptm_methylation','ptm_ubiquitination','ptm_cleavage', 'ptm_nitrosylation','ptm_acetylation', 'ptm_sumoylation', 'ptm_glycosylation', 'glycosylation_subtype', 'mobidb_disorder_propensity'],
                         sequence_properties=['linear_motif', 'structure']):
 
         rows = []
diff --git a/docs/metatable.csv b/docs/metatable.csv
index 1ba4d68e..2d967db3 100644
--- a/docs/metatable.csv
+++ b/docs/metatable.csv
@@ -1,16 +1,16 @@
-,aa_position,ref_aa,alt_aa,phosphorylation_site,methylation_site,ubiquitination_site,cleavage_site,s-nitrosylation_site,acetylation_site,sumoyylation_site,ogalnac_site,oglcnac_site,disorder_propensity,ptm_sources,linear_motif,structure,sources,cancer_study,cancer_type,genomic_coordinates,genomic_mutation,REVEL_score,cancer_site,cancer_histology,gnomad_exome_af,gnomad_genome_af,gnomad_popmax_exome_af,gnomad_popmax_genome_af,clinvar_variant_id,clinvar_germline_classification,clinvar_germline_condition,clinvar_germline_review_status,clinvar_oncogenicity_classification,clinvar_oncogenicity_condition,clinvar_oncogenicity_review_status,clinvar_clinical_impact_classification,clinvar_clinical_impact_condition,clinvar_clinical_impact_review_status
+,aa_position,ref_aa,alt_aa,phosphorylation_site,methylation_site,ubiquitination_site,cleavage_site,s-nitrosylation_site,acetylation_site,sumoyylation_site,glycosylation_site,glycosylation_subtype,disorder_propensity,ptm_sources,linear_motif,structure,sources,cancer_study,cancer_type,genomic_coordinates,genomic_mutation,REVEL_score,cancer_site,cancer_histology,gnomad_exome_af,gnomad_genome_af,gnomad_popmax_exome_af,gnomad_popmax_genome_af,clinvar_variant_id,clinvar_germline_classification,clinvar_germline_condition,clinvar_germline_review_status,clinvar_oncogenicity_classification,clinvar_oncogenicity_condition,clinvar_oncogenicity_review_status,clinvar_clinical_impact_classification,clinvar_clinical_impact_condition,clinvar_clinical_impact_review_status
 0,1,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
 1,2,P,R,,,,,,,,,,,,,,ClinVar,,,"hg19,16:87426038-87426038, hg38,16:87392432-87392432","hg19,16:g.87426038C>G, hg38,16:g.87392432C>G",0.145,,,0.0000000000000000,,,,2358122,Uncertain significance,not specified,1,,,,,,
 2,3,S,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
 3,4,E,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
-4,5,K,,,,Ubq,,,,,,,,PhosphoSite,"PCSK cleavage site (CLV_PCSK_SKI1_1), 5-9, ELM",,,,,,,,,,,,,,,,,,,,,,,
-5,6,T,,P,,,,,,,,,,PhosphoSite,"PCSK cleavage site (CLV_PCSK_SKI1_1), 5-9, ELM",,,,,,,,,,,,,,,,,,,,,,,
+4,5,K,,,,Ubq,,,,,Gly,,,PhosphoSite,"PCSK cleavage site (CLV_PCSK_SKI1_1), 5-9, ELM",,,,,,,,,,,,,,,,,,,,,,,
+5,6,T,,P,,,,,,,Gly,,,PhosphoSite,"PCSK cleavage site (CLV_PCSK_SKI1_1), 5-9, ELM",,,,,,,,,,,,,,,,,,,,,,,
 6,7,F,,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 5-9, ELM",,,,,,,,,,,,,,,,,,,,,,,
 7,8,K,,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 5-9, ELM",,,,,,,,,,,,,,,,,,,,,,,
 8,9,Q,,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 5-9, ELM",,,,,,,,,,,,,,,,,,,,,,,
 9,10,R,,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 10-12, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 10-14, ELM",,,,,,,,,,,,,,,,,,,,,,,
 10,11,R,L,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 10-12, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 10-14, ELM",,ClinVar,,,"hg19,16:87426065-87426065, hg38,16:87392459-87392459","hg19,16:g.87426065G>T, hg38,16:g.87392459G>T",0.226,,,0.0000000000000000,,,,2226367,Uncertain significance,not specified,1,,,,,,
-11,12,T,,P,,,,,,,,,,PhosphoSite,"NRD cleavage site (CLV_NRD_NRD_1), 10-12, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 10-14, ELM",,,,,,,,,,,,,,,,,,,,,,,
+11,12,T,,P,,,,,,,Gly,,,PhosphoSite,"NRD cleavage site (CLV_NRD_NRD_1), 10-12, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 10-14, ELM",,,,,,,,,,,,,,,,,,,,,,,
 12,13,F,,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 10-14, ELM",,,,,,,,,,,,,,,,,,,,,,,
 13,14,E,,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 10-14, ELM",,,,,,,,,,,,,,,,,,,,,,,
 14,15,Q,R,,,,,,,,,,,,,,ClinVar,,,"hg19,16:87432424-87432424, hg38,16:87398818-87398818","hg19,16:g.87432424A>G, hg38,16:g.87398818A>G",0.193,,,0.0000079532982328,,,,3542641,Uncertain significance,not specified,1,,,,,,
@@ -19,7 +19,7 @@
 17,18,E,,,,,,,,,,,,,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_1), 18-23, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_LyEn_5), 18-23, ELM",,,,,,,,,,,,,,,,,,,,,,,
 18,19,D,,,,,,,,,,,,,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_1), 18-23, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_LyEn_5), 18-23, ELM",,,,,,,,,,,,,,,,,,,,,,,
 19,20,V,,,,,,,,,,,,,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_1), 18-23, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_LyEn_5), 18-23, ELM",,,,,,,,,,,,,,,,,,,,,,,
-20,21,R,,,Me,,,,,,,,,PhosphoSite,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_1), 18-23, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_LyEn_5), 18-23, ELM",,,,,,,,,,,,,,,,,,,,,,,
+20,21,R,,,Me,,,,,,Gly,,,PhosphoSite,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_1), 18-23, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_LyEn_5), 18-23, ELM",,,,,,,,,,,,,,,,,,,,,,,
 21,22,L,,,,,,,,,,,,,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_1), 18-23, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_LyEn_5), 18-23, ELM",,,,,,,,,,,,,,,,,,,,,,,
 22,23,I,,,,,,,,,,,,,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_1), 18-23, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_LyEn_5), 18-23, ELM",,,,,,,,,,,,,,,,,,,,,,,
 23,24,R,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
@@ -27,9 +27,9 @@
 25,26,Q,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
 26,27,H,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
 27,28,P,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
-28,29,T,I,P,,,,,,,,,,PhosphoSite,,,ClinVar,,,"hg19,16:87432466-87432466, hg38,16:87398860-87398860","hg19,16:g.87432466C>T, hg38,16:g.87398860C>T",0.168,,,0.0000079527922254,,,,2493543,Uncertain significance,not specified,1,,,,,,
-29,29,T,N,P,,,,,,,,,,PhosphoSite,,,ClinVar,,,"hg19,16:87432466-87432466, hg38,16:87398860-87398860","hg19,16:g.87432466C>A, hg38,16:g.87398860C>A",0.067,,,0.0000278347727887,0.0000636739891754,,,4051121,Uncertain significance,not specified,1,,,,,,
-30,30,K,,,,Ubq,,,,,,,,PhosphoSite,,,,,,,,,,,,,,,,,,,,,,,,
+28,29,T,I,P,,,,,,,Gly,,,PhosphoSite,,,ClinVar,,,"hg19,16:87432466-87432466, hg38,16:87398860-87398860","hg19,16:g.87432466C>T, hg38,16:g.87398860C>T",0.168,,,0.0000079527922254,,,,2493543,Uncertain significance,not specified,1,,,,,,
+29,29,T,N,P,,,,,,,Gly,,,PhosphoSite,,,ClinVar,,,"hg19,16:87432466-87432466, hg38,16:87398860-87398860","hg19,16:g.87432466C>A, hg38,16:g.87398860C>A",0.067,,,0.0000278347727887,0.0000636739891754,,,4051121,Uncertain significance,not specified,1,,,,,,
+30,30,K,,,,Ubq,,,,,Gly,,,PhosphoSite,,,,,,,,,,,,,,,,,,,,,,,,
 31,31,I,,,,,,,,,,,,,"PP2A holoenzyme B56-docking site (DOC_PP2A_B56_1), 31-36, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 31-36, ELM",,,,,,,,,,,,,,,,,,,,,,,
 32,32,P,,,,,,,,,,,,,"PP2A holoenzyme B56-docking site (DOC_PP2A_B56_1), 31-36, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 31-36, ELM",,,,,,,,,,,,,,,,,,,,,,,
 33,33,V,,,,,,,,,,,,,"PP2A holoenzyme B56-docking site (DOC_PP2A_B56_1), 31-36, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 31-36, ELM",,,,,,,,,,,,,,,,,,,,,,,
@@ -41,7 +41,7 @@
 39,39,K,R,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 37-46, ELM",,cBioPortal,coadread_tcga_pan_can_atlas_2018,Colorectal Adenocarcinoma,"hg19,16:87435800-87435800","hg19,16:g.87435800A>G",0.065,,,,,,,,,,,,,,,,
 40,40,G,,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 37-46, ELM",,,,,,,,,,,,,,,,,,,,,,,
 41,41,E,,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 37-46, ELM",,,,,,,,,,,,,,,,,,,,,,,
-42,42,K,,,,Ubq,,,,,,,,PhosphoSite,"MAPK docking motifs (DOC_MAPK_gen_1), 37-46, ELM",,,,,,,,,,,,,,,,,,,,,,,
+42,42,K,,,,Ubq,,,,,Gly,,,PhosphoSite,"MAPK docking motifs (DOC_MAPK_gen_1), 37-46, ELM",,,,,,,,,,,,,,,,,,,,,,,
 43,43,Q,,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 37-46, ELM",,,,,,,,,,,,,,,,,,,,,,,
 44,44,L,F,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 37-46, ELM",,ClinVar,,,"hg19,16:87435814-87435814, hg38,16:87402208-87402208","hg19,16:g.87435814C>T, hg38,16:g.87402208C>T",0.359,,,,,,,2298840,Uncertain significance,not specified,1,,,,,,
 45,44,L,P,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 37-46, ELM",,ClinVar,,,"hg19,16:87435815-87435815, hg38,16:87402209-87402209","hg19,16:g.87435815T>C, hg38,16:g.87402209T>C",0.632,,,,,,,2298841,Uncertain significance,not specified,1,,,,,,
@@ -49,9 +49,9 @@
 47,46,V,,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 37-46, ELM",,,,,,,,,,,,,,,,,,,,,,,
 48,47,L,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
 49,48,D,,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 48-54, ELM",,,,,,,,,,,,,,,,,,,,,,,
-50,49,K,,,,Ubq,,,Ac,,,,,PhosphoSite,"FHA phosphopeptide ligands (LIG_FHA_1), 48-54, ELM",,,,,,,,,,,,,,,,,,,,,,,
-51,50,T,R,P,,,,,,,,,,PhosphoSite,"FHA phosphopeptide ligands (LIG_FHA_1), 48-54, ELM",,ClinVar,,,"hg19,16:87435833-87435833, hg38,16:87402227-87402227","hg19,16:g.87435833C>G, hg38,16:g.87402227C>G",0.415,,,0.0000039767440011,,,,3870023,Uncertain significance,not specified,1,,,,,,
-52,51,K,,,,Ubq,,,Ac,,,,,PhosphoSite,"FHA phosphopeptide ligands (LIG_FHA_1), 48-54, ELM",,,,,,,,,,,,,,,,,,,,,,,
+50,49,K,,,,Ubq,,,Ac,,Gly,,,PhosphoSite,"FHA phosphopeptide ligands (LIG_FHA_1), 48-54, ELM",,,,,,,,,,,,,,,,,,,,,,,
+51,50,T,R,P,,,,,,,Gly,,,PhosphoSite,"FHA phosphopeptide ligands (LIG_FHA_1), 48-54, ELM",,ClinVar,,,"hg19,16:87435833-87435833, hg38,16:87402227-87402227","hg19,16:g.87435833C>G, hg38,16:g.87402227C>G",0.415,,,0.0000039767440011,,,,3870023,Uncertain significance,not specified,1,,,,,,
+52,51,K,,,,Ubq,,,Ac,,Gly,,,PhosphoSite,"FHA phosphopeptide ligands (LIG_FHA_1), 48-54, ELM",,,,,,,,,,,,,,,,,,,,,,,
 53,52,F,,,,,,,,,,,,,"PP4 EVH1-binding docking motifs (DOC_PP4_FxxP_1), 52-55, ELM|FHA phosphopeptide ligands (LIG_FHA_1), 48-54, ELM",,,,,,,,,,,,,,,,,,,,,,,
 54,53,L,,,,,,,,,,,,,"PP4 EVH1-binding docking motifs (DOC_PP4_FxxP_1), 52-55, ELM|FHA phosphopeptide ligands (LIG_FHA_1), 48-54, ELM",,,,,,,,,,,,,,,,,,,,,,,
 55,54,V,,,,,,,,,,,,,"PP4 EVH1-binding docking motifs (DOC_PP4_FxxP_1), 52-55, ELM|Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 54-58, ELM|FHA phosphopeptide ligands (LIG_FHA_1), 48-54, ELM",,,,,,,,,,,,,,,,,,,,,,,
@@ -65,7 +65,7 @@
 63,62,E,,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 62-77, ELM",,,,,,,,,,,,,,,,,,,,,,,
 64,63,L,,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 62-77, ELM",,,,,,,,,,,,,,,,,,,,,,,
 65,64,I,,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 62-77, ELM",,,,,,,,,,,,,,,,,,,,,,,
-66,65,K,E,,,Ubq,,,,,,,,PhosphoSite,"MAPK docking motifs (DOC_MAPK_gen_1), 65-73, ELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 62-77, ELM",,"cBioPortal,COSMIC",coadread_genentech,Colorectal Adenocarcinoma,"hg19,16:87435877-87435877, hg38,16:87402271-87402271","hg19,16:g.87435877A>G, hg38,16:g.87402271A>G",0.314,"large_intestine, colon","carcinoma, adenocarcinoma",0.0000278640235650,,,,,,,,,,,,,
+66,65,K,E,,,Ubq,,,,,Gly,,,PhosphoSite,"MAPK docking motifs (DOC_MAPK_gen_1), 65-73, ELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 62-77, ELM",,"cBioPortal,COSMIC",coadread_genentech,Colorectal Adenocarcinoma,"hg19,16:87435877-87435877, hg38,16:87402271-87402271","hg19,16:g.87435877A>G, hg38,16:g.87402271A>G",0.314,"large_intestine, colon","carcinoma, adenocarcinoma",0.0000278640235650,,,,,,,,,,,,,
 67,66,I,,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 65-73, ELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 62-77, ELM",,,,,,,,,,,,,,,,,,,,,,,
 68,67,I,,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 65-73, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 67-70, ELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 62-77, ELM",,,,,,,,,,,,,,,,,,,,,,,
 69,68,R,,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 65-73, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 67-70, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 68-70, ELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 62-77, ELM",,,,,,,,,,,,,,,,,,,,,,,
diff --git a/docs/metatable_non_canonical.csv b/docs/metatable_non_canonical.csv
index 814aaeee..58f83ce8 100644
--- a/docs/metatable_non_canonical.csv
+++ b/docs/metatable_non_canonical.csv
@@ -1,4 +1,4 @@
-,aa_position,ref_aa,alt_aa,phosphorylation_site,methylation_site,ubiquitination_site,cleavage_site,s-nitrosylation_site,acetylation_site,sumoyylation_site,ogalnac_site,oglcnac_site,disorder_propensity,ptm_sources,linear_motif,structure,sources,cancer_study,cancer_type,genomic_coordinates,genomic_mutation,REVEL_score,cancer_site,cancer_histology,gnomad_exome_af,gnomad_genome_af,gnomad_popmax_exome_af,gnomad_popmax_genome_af,clinvar_variant_id,clinvar_germline_classification,clinvar_germline_condition,clinvar_germline_review_status,clinvar_oncogenicity_classification,clinvar_oncogenicity_condition,clinvar_oncogenicity_review_status,clinvar_clinical_impact_classification,clinvar_clinical_impact_condition,clinvar_clinical_impact_review_status
+,aa_position,ref_aa,alt_aa,phosphorylation_site,methylation_site,ubiquitination_site,cleavage_site,s-nitrosylation_site,acetylation_site,sumoyylation_site,glycosylation_site,glycosylation_subtype,disorder_propensity,ptm_sources,linear_motif,structure,sources,cancer_study,cancer_type,genomic_coordinates,genomic_mutation,REVEL_score,cancer_site,cancer_histology,gnomad_exome_af,gnomad_genome_af,gnomad_popmax_exome_af,gnomad_popmax_genome_af,clinvar_variant_id,clinvar_germline_classification,clinvar_germline_condition,clinvar_germline_review_status,clinvar_oncogenicity_classification,clinvar_oncogenicity_condition,clinvar_oncogenicity_review_status,clinvar_clinical_impact_classification,clinvar_clinical_impact_condition,clinvar_clinical_impact_review_status
 0,1,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
 1,2,K,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
 2,3,V,D,,,,,,,,,,,,,,COSMIC,,,"hg38,11:46548373-46548373","hg38,11:g.46548373A>T",0.373,large_intestine,"carcinoma, adenocarcinoma",,,,,,,,,,,,,,
diff --git a/docs/metatable_pancancer.csv b/docs/metatable_pancancer.csv
index 0a2cbcf5..930fe5c9 100644
--- a/docs/metatable_pancancer.csv
+++ b/docs/metatable_pancancer.csv
@@ -1,18 +1,18 @@
-,aa_position,ref_aa,alt_aa,phosphorylation_site,methylation_site,ubiquitination_site,cleavage_site,s-nitrosylation_site,acetylation_site,sumoyylation_site,ogalnac_site,oglcnac_site,disorder_propensity,ptm_sources,linear_motif,structure,sources,cancer_study,cancer_type,genomic_coordinates,genomic_mutation,REVEL_score,cancer_site,cancer_histology,gnomad_exome_af,gnomad_genome_af,gnomad_popmax_exome_af,gnomad_popmax_genome_af,clinvar_variant_id,clinvar_germline_classification,clinvar_germline_condition,clinvar_germline_review_status,clinvar_oncogenicity_classification,clinvar_oncogenicity_condition,clinvar_oncogenicity_review_status,clinvar_clinical_impact_classification,clinvar_clinical_impact_condition,clinvar_clinical_impact_review_status
+,aa_position,ref_aa,alt_aa,phosphorylation_site,methylation_site,ubiquitination_site,cleavage_site,s-nitrosylation_site,acetylation_site,sumoyylation_site,glycosylation_site,glycosylation_subtype,disorder_propensity,ptm_sources,linear_motif,structure,sources,cancer_study,cancer_type,genomic_coordinates,genomic_mutation,REVEL_score,cancer_site,cancer_histology,gnomad_exome_af,gnomad_genome_af,gnomad_popmax_exome_af,gnomad_popmax_genome_af,clinvar_variant_id,clinvar_germline_classification,clinvar_germline_condition,clinvar_germline_review_status,clinvar_oncogenicity_classification,clinvar_oncogenicity_condition,clinvar_oncogenicity_review_status,clinvar_clinical_impact_classification,clinvar_clinical_impact_condition,clinvar_clinical_impact_review_status
 0,1,M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
 1,2,P,R,,,,,,,,,,,,,,ClinVar,,,"hg19,16:87426038-87426038, hg38,16:87392432-87392432","hg19,16:g.87426038C>G, hg38,16:g.87392432C>G",0.145,,,0.0000000000000000,,,,2358122,Uncertain significance,not specified,1,,,,,,
 2,2,P,S,,,,,,,,,,,,,,cBioPortal,"ccle_broad_2019, ccle_broad_2025, ccle_genentech_2014",Mixed Cancer Types,"hg19,16:87392431-87392431, hg19,16:87426037-87426037","hg19,16:g.87392431C>T, hg19,16:g.87426037C>T",0.055,,,0.0000405975966223,,,,,,,,,,,,,
 3,3,S,L,,,,,,,,,,,,,,COSMIC,,,"hg38,16:87392435-87392435","hg38,16:g.87392435C>T",0.227,"eye, urinary_tract, bladder","carcinoma, small_cell_carcinoma, retinoblastoma",0.0012579161967554,,,,,,,,,,,,,
 4,3,S,W,,,,,,,,,,,,,,COSMIC,,,"hg38,16:87392435-87392435","hg38,16:g.87392435C>G",0.158,oesophagus,"carcinoma, squamous_cell_carcinoma",0.0000216882102889,0.0000321957501610,,,,,,,,,,,,
 5,4,E,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
-6,5,K,,,,Ubq,,,,,,,,PhosphoSite,"PCSK cleavage site (CLV_PCSK_SKI1_1), 5-9, ELM",,,,,,,,,,,,,,,,,,,,,,,
-7,6,T,,P,,,,,,,,,,PhosphoSite,"PCSK cleavage site (CLV_PCSK_SKI1_1), 5-9, ELM",,,,,,,,,,,,,,,,,,,,,,,
+6,5,K,,,,Ubq,,,,,Gly,,,PhosphoSite,"PCSK cleavage site (CLV_PCSK_SKI1_1), 5-9, ELM",,,,,,,,,,,,,,,,,,,,,,,
+7,6,T,,P,,,,,,,Gly,,,PhosphoSite,"PCSK cleavage site (CLV_PCSK_SKI1_1), 5-9, ELM",,,,,,,,,,,,,,,,,,,,,,,
 8,7,F,,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 5-9, ELM",,,,,,,,,,,,,,,,,,,,,,,
 9,8,K,N,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 5-9, ELM",,COSMIC,,,"hg38,16:87392451-87392451","hg38,16:g.87392451G>T",0.159,"skin, back","adnexal_tumour, malignant_adnexal_tumour, spiradenocarcinoma",0.0000000000000000,,,,,,,,,,,,,
 10,9,Q,H,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 5-9, ELM",,cBioPortal,pancan_pdmr_2025,Mixed Cancer Types,"hg19,16:87426060-87426060","hg19,16:g.87426060G>C",0.156,,,,,,,,,,,,,,,,
 11,10,R,,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 10-12, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 10-14, ELM",,,,,,,,,,,,,,,,,,,,,,,
 12,11,R,L,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 10-12, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 10-14, ELM",,"cBioPortal,ClinVar",lusc_cptac_2021,Lung Squamous Cell Carcinoma,"hg19,16:87426065-87426065, hg38,16:87392459-87392459","hg19,16:g.87426065G>T, hg38,16:g.87392459G>T",0.226,,,0.0000000000000000,,,,2226367,Uncertain significance,not specified,1,,,,,,
-13,12,T,S,P,,,,,,,,,,PhosphoSite,"NRD cleavage site (CLV_NRD_NRD_1), 10-12, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 10-14, ELM",,COSMIC,,,"hg38,16:87392461-87392461","hg38,16:g.87392461A>T",0.097,"haematopoietic_and_lymphoid_tissue, abdomen","lymphoid_neoplasm, Burkitt_lymphoma, endemic_variant",,,,,,,,,,,,,,
+13,12,T,S,P,,,,,,,Gly,,,PhosphoSite,"NRD cleavage site (CLV_NRD_NRD_1), 10-12, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 10-14, ELM",,COSMIC,,,"hg38,16:87392461-87392461","hg38,16:g.87392461A>T",0.097,"haematopoietic_and_lymphoid_tissue, abdomen","lymphoid_neoplasm, Burkitt_lymphoma, endemic_variant",,,,,,,,,,,,,,
 14,13,F,,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 10-14, ELM",,,,,,,,,,,,,,,,,,,,,,,
 15,14,E,,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 10-14, ELM",,,,,,,,,,,,,,,,,,,,,,,
 16,15,Q,R,,,,,,,,,,,,,,ClinVar,,,"hg19,16:87432424-87432424, hg38,16:87398818-87398818","hg19,16:g.87432424A>G, hg38,16:g.87398818A>G",0.193,,,0.0000079532982328,,,,3542641,Uncertain significance,not specified,1,,,,,,
@@ -21,8 +21,8 @@
 19,18,E,,,,,,,,,,,,,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_1), 18-23, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_LyEn_5), 18-23, ELM",,,,,,,,,,,,,,,,,,,,,,,
 20,19,D,Y,,,,,,,,,,,,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_1), 18-23, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_LyEn_5), 18-23, ELM",,cBioPortal,mixed_pipseq_2017,Mixed Cancer Types,"hg19,16:87432435-87432435","hg19,16:g.87432435G>T",0.524,,,,,,,,,,,,,,,,
 21,20,V,,,,,,,,,,,,,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_1), 18-23, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_LyEn_5), 18-23, ELM",,,,,,,,,,,,,,,,,,,,,,,
-22,21,R,G,,Me,,,,,,,,,PhosphoSite,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_1), 18-23, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_LyEn_5), 18-23, ELM",,cBioPortal,skcm_tcga,Cutaneous Melanoma,"hg19,16:87432441-87432441","hg19,16:g.87432441C>G",0.125,,,,,,,,,,,,,,,,
-23,21,R,Q,,Me,,,,,,,,,PhosphoSite,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_1), 18-23, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_LyEn_5), 18-23, ELM",,"cBioPortal,COSMIC","coad_cptac_2019, pancan_pdmr_2025, ucec_tcga, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub, ucs_jhu_2014","Colon Adenocarcinoma, Endometrial Carcinoma, Mixed Cancer Types, Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor","hg19,16:87398836-87398836, hg19,16:87432442-87432442, hg38,16:87398836-87398836","hg19,16:g.87398836G>A, hg19,16:g.87432442G>A, hg38,16:g.87398836G>A",0.066,endometrium,"carcinoma, endometrioid_carcinoma",0.0000079526657336,,,,,,,,,,,,,
+22,21,R,G,,Me,,,,,,Gly,,,PhosphoSite,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_1), 18-23, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_LyEn_5), 18-23, ELM",,cBioPortal,skcm_tcga,Cutaneous Melanoma,"hg19,16:87432441-87432441","hg19,16:g.87432441C>G",0.125,,,,,,,,,,,,,,,,
+23,21,R,Q,,Me,,,,,,Gly,,,PhosphoSite,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_1), 18-23, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_LyEn_5), 18-23, ELM",,"cBioPortal,COSMIC","coad_cptac_2019, pancan_pdmr_2025, ucec_tcga, ucec_tcga_gdc, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub, ucs_jhu_2014","Colon Adenocarcinoma, Endometrial Carcinoma, Mixed Cancer Types, Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor","hg19,16:87398836-87398836, hg19,16:87432442-87432442, hg38,16:87398836-87398836","hg19,16:g.87398836G>A, hg19,16:g.87432442G>A, hg38,16:g.87398836G>A",0.066,endometrium,"carcinoma, endometrioid_carcinoma",0.0000079526657336,,,,,,,,,,,,,
 24,22,L,,,,,,,,,,,,,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_1), 18-23, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_LyEn_5), 18-23, ELM",,,,,,,,,,,,,,,,,,,,,,,
 25,23,I,F,,,,,,,,,,,,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_1), 18-23, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_LyEn_5), 18-23, ELM",,"cBioPortal,COSMIC",nsclc_mskcc_2018,Non-Small Cell Lung Cancer,"hg19,16:87432447-87432447, hg38,16:87398841-87398841","hg19,16:g.87432447A>T, hg38,16:g.87398841A>T",0.632,lung,"carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
 26,24,R,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
@@ -30,10 +30,10 @@
 28,26,Q,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
 29,27,H,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
 30,28,P,L,,,,,,,,,,,,,,"cBioPortal,COSMIC","skcm_tcga_gdc, skcm_tcga_pan_can_atlas_2018, skcm_tcga_pub_2015",Cutaneous Melanoma,"hg19,16:87398857-87398857, hg19,16:87432463-87432463, hg38,16:87398857-87398857","hg19,16:g.87398857C>T, hg19,16:g.87432463C>T, hg38,16:g.87398857C>T",0.411,skin,malignant_melanoma,,,,,,,,,,,,,,
-31,29,T,A,P,,,,,,,,,,PhosphoSite,,,"cBioPortal,COSMIC",gbc_shanghai_2014,Gallbladder Cancer,"hg19,16:87432465-87432465, hg38,16:87398859-87398859","hg19,16:g.87432465A>G, hg38,16:g.87398859A>G",0.147,"biliary_tract, gallbladder","carcinoma, adenocarcinoma",,0.0000955170657157,,,,,,,,,,,,
-32,29,T,I,P,,,,,,,,,,PhosphoSite,,,ClinVar,,,"hg19,16:87432466-87432466, hg38,16:87398860-87398860","hg19,16:g.87432466C>T, hg38,16:g.87398860C>T",0.168,,,0.0000079527922254,,,,2493543,Uncertain significance,not specified,1,,,,,,
-33,29,T,N,P,,,,,,,,,,PhosphoSite,,,ClinVar,,,"hg19,16:87432466-87432466, hg38,16:87398860-87398860","hg19,16:g.87432466C>A, hg38,16:g.87398860C>A",0.067,,,0.0000278347727887,0.0000636739891754,,,4051121,Uncertain significance,not specified,1,,,,,,
-34,30,K,,,,Ubq,,,,,,,,PhosphoSite,,,,,,,,,,,,,,,,,,,,,,,,
+31,29,T,A,P,,,,,,,Gly,,,PhosphoSite,,,"cBioPortal,COSMIC",gbc_shanghai_2014,Gallbladder Cancer,"hg19,16:87432465-87432465, hg38,16:87398859-87398859","hg19,16:g.87432465A>G, hg38,16:g.87398859A>G",0.147,"biliary_tract, gallbladder","carcinoma, adenocarcinoma",,0.0000955170657157,,,,,,,,,,,,
+32,29,T,I,P,,,,,,,Gly,,,PhosphoSite,,,ClinVar,,,"hg19,16:87432466-87432466, hg38,16:87398860-87398860","hg19,16:g.87432466C>T, hg38,16:g.87398860C>T",0.168,,,0.0000079527922254,,,,2493543,Uncertain significance,not specified,1,,,,,,
+33,29,T,N,P,,,,,,,Gly,,,PhosphoSite,,,ClinVar,,,"hg19,16:87432466-87432466, hg38,16:87398860-87398860","hg19,16:g.87432466C>A, hg38,16:g.87398860C>A",0.067,,,0.0000278347727887,0.0000636739891754,,,4051121,Uncertain significance,not specified,1,,,,,,
+34,30,K,,,,Ubq,,,,,Gly,,,PhosphoSite,,,,,,,,,,,,,,,,,,,,,,,,
 35,31,I,N,,,,,,,,,,,,"PP2A holoenzyme B56-docking site (DOC_PP2A_B56_1), 31-36, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 31-36, ELM",,cBioPortal,pancan_pdmr_2025,Mixed Cancer Types,"hg19,16:87432472-87432472","hg19,16:g.87432472T>A",0.716,,,,,,,,,,,,,,,,
 36,32,P,L,,,,,,,,,,,,"PP2A holoenzyme B56-docking site (DOC_PP2A_B56_1), 31-36, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 31-36, ELM",,"cBioPortal,COSMIC",bcc_unige_2016,Basal Cell Carcinoma,"hg19,16:87432474-87432475, hg38,16:87398868-87398869","hg19,16:g.87432474_87432475delinsTT, hg38,16:g.87398868_87398869delinsTT",,skin,"carcinoma, basal_cell_carcinoma",,,,,,,,,,,,,,
 37,32,P,Q,,,,,,,,,,,,"PP2A holoenzyme B56-docking site (DOC_PP2A_B56_1), 31-36, ELM|SUMO interaction site (LIG_SUMO_SIM_par_1), 31-36, ELM",,cBioPortal,lusc_tcga_pub,Lung Squamous Cell Carcinoma,"hg19,16:87432475-87432475","hg19,16:g.87432475C>A",0.755,,,,,,,,,,,,,,,,
@@ -47,7 +47,7 @@
 45,39,K,R,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 37-46, ELM",,"cBioPortal,COSMIC","coad_tcga_gdc, coadread_tcga_pan_can_atlas_2018","Colon Adenocarcinoma, Colorectal Adenocarcinoma","hg19,16:87402194-87402194, hg19,16:87435800-87435800, hg38,16:87402194-87402194","hg19,16:g.87402194A>G, hg19,16:g.87435800A>G, hg38,16:g.87402194A>G",0.065,"large_intestine, caecum","carcinoma, adenocarcinoma",,,,,,,,,,,,,,
 46,40,G,,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 37-46, ELM",,,,,,,,,,,,,,,,,,,,,,,
 47,41,E,,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 37-46, ELM",,,,,,,,,,,,,,,,,,,,,,,
-48,42,K,,,,Ubq,,,,,,,,PhosphoSite,"MAPK docking motifs (DOC_MAPK_gen_1), 37-46, ELM",,,,,,,,,,,,,,,,,,,,,,,
+48,42,K,,,,Ubq,,,,,Gly,,,PhosphoSite,"MAPK docking motifs (DOC_MAPK_gen_1), 37-46, ELM",,,,,,,,,,,,,,,,,,,,,,,
 49,43,Q,,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 37-46, ELM",,,,,,,,,,,,,,,,,,,,,,,
 50,44,L,F,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 37-46, ELM",,ClinVar,,,"hg19,16:87435814-87435814, hg38,16:87402208-87402208","hg19,16:g.87435814C>T, hg38,16:g.87402208C>T",0.359,,,,,,,2298840,Uncertain significance,not specified,1,,,,,,
 51,44,L,P,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 37-46, ELM",,ClinVar,,,"hg19,16:87435815-87435815, hg38,16:87402209-87402209","hg19,16:g.87435815T>C, hg38,16:g.87402209T>C",0.632,,,,,,,2298841,Uncertain significance,not specified,1,,,,,,
@@ -55,10 +55,10 @@
 53,46,V,F,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 37-46, ELM",,cBioPortal,hgsoc_tcga_gdc,High-Grade Serous Ovarian Cancer,"hg19,16:87402214-87402214","hg19,16:g.87402214G>T",,,,,,,,,,,,,,,,,
 54,47,L,M,,,,,,,,,,,,,,cBioPortal,pancan_pdmr_2025,Mixed Cancer Types,"hg19,16:87435823-87435823","hg19,16:g.87435823C>A",0.340,,,,,,,,,,,,,,,,
 55,48,D,Y,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 48-54, ELM",,cBioPortal,cscc_ranson_2022,Cutaneous Squamous Cell Carcinoma,"hg19,16:87402220-87402220","hg19,16:g.87402220G>T",,,,,,,,,,,,,,,,,
-56,49,K,N,,,Ubq,,,Ac,,,,,PhosphoSite,"FHA phosphopeptide ligands (LIG_FHA_1), 48-54, ELM",,"cBioPortal,COSMIC","mixed_allen_2018, skcm_dfci_2015","Cutaneous Melanoma, Mixed Cancer Types","hg19,16:87435831-87435831, hg38,16:87402225-87402225","hg19,16:g.87435831A>C, hg38,16:g.87402225A>C",0.495,skin,malignant_melanoma,,,,,,,,,,,,,,
-57,50,T,I,P,,,,,,,,,,PhosphoSite,"FHA phosphopeptide ligands (LIG_FHA_1), 48-54, ELM",,COSMIC,,,"hg38,16:87402227-87402227","hg38,16:g.87402227C>T",0.502,"upper_aerodigestive_tract, mouth, gingiva","carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
-58,50,T,R,P,,,,,,,,,,PhosphoSite,"FHA phosphopeptide ligands (LIG_FHA_1), 48-54, ELM",,ClinVar,,,"hg19,16:87435833-87435833, hg38,16:87402227-87402227","hg19,16:g.87435833C>G, hg38,16:g.87402227C>G",0.415,,,0.0000039767440011,,,,3870023,Uncertain significance,not specified,1,,,,,,
-59,51,K,,,,Ubq,,,Ac,,,,,PhosphoSite,"FHA phosphopeptide ligands (LIG_FHA_1), 48-54, ELM",,,,,,,,,,,,,,,,,,,,,,,
+56,49,K,N,,,Ubq,,,Ac,,Gly,,,PhosphoSite,"FHA phosphopeptide ligands (LIG_FHA_1), 48-54, ELM",,"cBioPortal,COSMIC","mixed_allen_2018, skcm_dfci_2015","Cutaneous Melanoma, Mixed Cancer Types","hg19,16:87435831-87435831, hg38,16:87402225-87402225","hg19,16:g.87435831A>C, hg38,16:g.87402225A>C",0.495,skin,malignant_melanoma,,,,,,,,,,,,,,
+57,50,T,I,P,,,,,,,Gly,,,PhosphoSite,"FHA phosphopeptide ligands (LIG_FHA_1), 48-54, ELM",,COSMIC,,,"hg38,16:87402227-87402227","hg38,16:g.87402227C>T",0.502,"upper_aerodigestive_tract, mouth, gingiva","carcinoma, squamous_cell_carcinoma",,,,,,,,,,,,,,
+58,50,T,R,P,,,,,,,Gly,,,PhosphoSite,"FHA phosphopeptide ligands (LIG_FHA_1), 48-54, ELM",,ClinVar,,,"hg19,16:87435833-87435833, hg38,16:87402227-87402227","hg19,16:g.87435833C>G, hg38,16:g.87402227C>G",0.415,,,0.0000039767440011,,,,3870023,Uncertain significance,not specified,1,,,,,,
+59,51,K,,,,Ubq,,,Ac,,Gly,,,PhosphoSite,"FHA phosphopeptide ligands (LIG_FHA_1), 48-54, ELM",,,,,,,,,,,,,,,,,,,,,,,
 60,52,F,,,,,,,,,,,,,"PP4 EVH1-binding docking motifs (DOC_PP4_FxxP_1), 52-55, ELM|FHA phosphopeptide ligands (LIG_FHA_1), 48-54, ELM",,,,,,,,,,,,,,,,,,,,,,,
 61,53,L,,,,,,,,,,,,,"PP4 EVH1-binding docking motifs (DOC_PP4_FxxP_1), 52-55, ELM|FHA phosphopeptide ligands (LIG_FHA_1), 48-54, ELM",,,,,,,,,,,,,,,,,,,,,,,
 62,54,V,,,,,,,,,,,,,"PP4 EVH1-binding docking motifs (DOC_PP4_FxxP_1), 52-55, ELM|Arc N-lobe binding ligand (LIG_Arc_Nlobe_1), 54-58, ELM|FHA phosphopeptide ligands (LIG_FHA_1), 48-54, ELM",,,,,,,,,,,,,,,,,,,,,,,
@@ -74,7 +74,7 @@
 72,62,E,,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 62-77, ELM",,,,,,,,,,,,,,,,,,,,,,,
 73,63,L,F,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 62-77, ELM",,COSMIC,,,"hg38,16:87402265-87402265","hg38,16:g.87402265C>T",0.293,"skin, head_neck","malignant_melanoma, nodular",,,,,,,,,,,,,,
 74,64,I,,,,,,,,,,,,,"NES Nuclear Export Signals (TRG_NES_CRM1_1), 62-77, ELM",,,,,,,,,,,,,,,,,,,,,,,
-75,65,K,E,,,Ubq,,,,,,,,PhosphoSite,"MAPK docking motifs (DOC_MAPK_gen_1), 65-73, ELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 62-77, ELM",,"cBioPortal,COSMIC",coadread_genentech,Colorectal Adenocarcinoma,"hg19,16:87435877-87435877, hg38,16:87402271-87402271","hg19,16:g.87435877A>G, hg38,16:g.87402271A>G",0.314,"large_intestine, colon","carcinoma, adenocarcinoma",0.0000278640235650,,,,,,,,,,,,,
+75,65,K,E,,,Ubq,,,,,Gly,,,PhosphoSite,"MAPK docking motifs (DOC_MAPK_gen_1), 65-73, ELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 62-77, ELM",,"cBioPortal,COSMIC",coadread_genentech,Colorectal Adenocarcinoma,"hg19,16:87435877-87435877, hg38,16:87402271-87402271","hg19,16:g.87435877A>G, hg38,16:g.87402271A>G",0.314,"large_intestine, colon","carcinoma, adenocarcinoma",0.0000278640235650,,,,,,,,,,,,,
 76,66,I,,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 65-73, ELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 62-77, ELM",,,,,,,,,,,,,,,,,,,,,,,
 77,67,I,,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 65-73, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 67-70, ELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 62-77, ELM",,,,,,,,,,,,,,,,,,,,,,,
 78,68,R,,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_gen_1), 65-73, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 67-70, ELM|di Arginine retention/retrieving signal (TRG_ER_diArg_1), 68-70, ELM|NES Nuclear Export Signals (TRG_NES_CRM1_1), 62-77, ELM",,,,,,,,,,,,,,,,,,,,,,,
diff --git a/docs/my_table.pdf b/docs/my_table.pdf
index 1dfc701dd49dcff98905a729b77190c500ec5833..6ee3e9b04c2a211596ccd24807d0e611013788c1 100644
GIT binary patch
delta 6926
zcmZu!Wk6Kzw*Cx|7*ZM~1*B(B52+wX=TO5)cMJ$f%O(ayN+gsP5TumuFenK{DM1NA
zL`0Dgq=k#$J?A_3Fn9mj`+e85*0a`n_S)}$*L`B5??h$%39unPMDbZZ?~_tU*WSE-
zwUmyVvt+!DiMtE0n|gYx=Djg5-<rLZEoHw4!ac*EH?Y-mL+Ongy|2)J-KJD$<O^GF
zVX!!SlX<`5f#Ore;DDx<OfYC?LWfRq_Twnutp}?s4<fjD=01+<d}?^$Cxx|^3<+*I
z9OR0({Jej7*fatDzUjBc!x3_7aBgbg3jeTGE$fH$T!}iSRyB%E-#cdWq^p{@D{t3@
zc7FlSe^b5TW9@lqI57nZG$rQiJNq97Zio1zC)<jyhLIQsx$MJzWkvJphPsO5J1moM
zy_&o0s|Pd;`)|SnoeUMh)(N$p1DA$V@rjoMY&Eiri%A<`_pXLCM4IKrhZ0sFaLa8w
z%jh#Qw>Y1=NSnJGB$nzMoUxkzdiF*KHwHbAaa?OPR=t@)<Tz|9>E;qI_&HFlfmEHl
zEBH#SFei?^)apl8W=yz|K$D$~ockv9pvEwslsMfK_|t9lReK0A#+mp<%6gbSwR_rY
zzuxT&O*t*dbkS93vdZ+7V^J39zTiG@CC;Yq?5Z2b!*Te&M3_tN!(xWn_#172W`MfV
zX}_0N3|(2C)w1=9Wn##7|H{v|9ek>kL(_~HDV6cqP*h&*RK>O>mY`N!JQEPWnhi;A
zc$DHP#+lrG*?(t!`5<;`>Z(h0N9?mZ{5!EGEzjsc%ZmYy+jnNWEPWX)mvVln=J|fe
zH!P~HFN9J|v#Od)5@MJ&MISYqakL4<UH>|w)|m45PB(_?Y`Cu8UBApoK)l`bj!r76
z%#y}%=9=~6TTm${iHPfZXc}7+5;iNtt=Tv7(qTI%Z-=jYqsCvlA3_b8PX&)@a6;Y%
zjDnZqa#z{UDi_Mr--q;CZ5Ab#RxNn;=2mXld2R$XC15P79`6!TrH!i|=QQCQ0ioD?
zi2*_y7gu9clpPl09_KuLF3!e~ZW8?HWQD0!dZCK#=p4I$@5$JhLbTM9jS8&M2AViN
zu1ud`B5{J*mDlRACR@UN31cOjcp(e<;4sicf=i&oDeBuSZL3XH;*KZnyk{39|5{9$
z@r+PxM}7+9dt(O68P<N6OBNL0ST(<oN6ZQJyCpH`IxtPQxZEea&u5PG&K0nHE*obv
z_F1i}{=C-B;R7W$gkKw9TaGsKw7KgIPyDaIcdv8gLy~*V9<&VTRd_6!P_OrOh29<o
zzfYj{=pWj5u_f*Oy+MQTm~T+9iSpgueErmrky4XNHE>Z@x$Wt!wz<}&)7(1g79Xod
z(d$K<H`%3(Ydp$opLbUjY>90roW;FCym1I%@#L&hHu(57T-XrF#3fjHdp8$u9Yv$0
zb-IFeGgYhcQWoPf+oVP$FMB)Wx)NA4vzX+ONe#y_+VGfiWIv~3k3JhH0<F8S|0NQt
zOu>(EpS^)sJwidPCRv&e)1k^)j6js1g4v@S2rG#x`GfhR6^dCqYHz-#v@|w&CzW%i
z+ISqnm_C9=NqW_%+y4(X@zo8ezP%(Y`n7pRH9I08H8Oz}r{%~#WCIp8;7b$YgAZ0)
zZhf2#69XiZ!W6f<Rww!`r=NWp-l^?zgBV}b3j?Y63-!_-C<LbIbV|K@b4amY%~0l}
zG=faIA3nAhoj9d_Mll-U)nv$)AGlxmAr(Wcy4=f1$S{NEtQtNpp8}%Hg>1r^GJ*hR
zuv)`7+Y@7bSI{nN59B!08Rt@ldKx#ptn?y7K3v7-xjY3R7~AENB7T+q+?m++Ww-Xu
z>MoO9y<S)LSHAbCR4!ih4B5AM92Tvr;_T4Jkmeqo@Z*E`(r=bax{fEz9p>q4yyo_A
zf=CZR+sE|}3WifZ!Sv&K(bcodXR&hI_WZi~aS8W$POb7uxD|rl)buZDs*rE9^XE>E
zZ_I{IYO|l`swYNr#hMqGF-HgIZE!eR6*z6RmH#4XLj$XO0wdYX9hg5nXJ8npkT;pa
z;y7<mQJ*j{<ri521~z=(TIh{+Pw@SASxFP>6`sotDKoxUxl+J!k-nq4_4z<TdPEZ<
zXU^^$1IpVA;SGWjO|f&<OpxMp7ED>XF)nlUpO~d$!}mzMwPG8q_a$a>Rp&q}hYGqB
z&0C9ew6*-D2M<*~Slu}kGI%otBJ?jjmd~nwuTY_0cz(C)p^B)kDD0rBVB&^$sNi}E
zA}dP6p7StG@S>dThysrL$0u=Wfb;3)_rwvqYl0JW<`u4BLCcG-%FE5%_0A6(e8wz&
zCv$zcbzmNP&AJoJAK%u;d{oHO&f|ZpJ+K?4hQ^L^3uI%SnX&Km1t8-@abVizDMgB6
zb+m(rbV?Ve$3t!PH_*zjV53;Maq3%9)zg!6lL;D)U)vHCwg&?C8g{XY65_;>htV4R
zLr7cvr6d86FaK($;mm|glA&Kz=vACg+iv9Uqfwd9>o9@k9HP+Klja`TbvXlN8BY`q
z%Y~$;##I(e?gFevLpY?4OU2EF>bX4MH(ZijS5`j9amt_1cgHQ#W*_Vq%?{*-d-4xm
z7rv~^o&EN;nFddkw-+V4bjLLrA5%F(s!PL05!uk7%O<xg?-VD4Y`6D_BHdq4-8W`}
z8Sy$I<>tTk+k2H}7K3f&US*uBl5Y=ce`pE`yH{h*PNLHodR_2?@Tm5)Dk<_3?NAVP
z#M+D3oUWubSeJ81u+3}iW2J}PJAMX+q5Z`h@}u?VR7=Hux~hHf<7%qTt##94eaU0<
zsVuRV!HRE&B|j_XuXNQv6kQJ-=$(GI({_JUOR_D~d5FhfPTYsU#_?<LMH;<OL(I?Z
zABV_pbd;!p&sE8I-=My9Y@@8p^;+(NyS#H%bE;3La;v=P4HEEtpk0K{YpIDe*I%=A
zADo15_1~eE=AF(}rc!Ly{8`L8=nU=YHN%$VErM}D)e^~L4Oe3dZB?N9-E;Q_EW!Oc
z?6Uec$Be`|q}C5g$pE-dm(L`$j+=DqFLUM_GQ_k}%6Zd-?Z!=(R25giOx`_W^~IH>
z0acFP5of}CT5s!&lV|Scj~Y7gW&sdR0>}BvU0I744=a}Ia9p)|PRRDVx351JVD$-@
zHw1m;(O-JoJf0C{YCSb=5x&hmgU}w7Y6WgXUibUr`k9XYhH$jZnDb8;U93saz(Fg`
zT}aq%{=IdGd6JVT{I%FN7*aAJky}NC-!j%bJ3Tnn=Xlq=H9wJdj>(*(`Hf^s`zl?`
z(clypUbxBDXWf($>BV8;B!KoN(o|nq2U83!%8Rl_Ov+3CeSR=z8~ax4qLaK%z`LTZ
z1~3hC*xpBp%r#sBBt(keCM2wqex%vzIo+C#6f>1|EXoh=H7bs#UoKed#bvT}XtK`x
z4rr^CnFpS{!|8gdR9^mYmQ4aW&eXS%m$-j{H*xJjrc1`ePFneVYPlN&*x}Ldo6~<$
zgKqv+r-3r3G_n@q?Mu@qZEz8Jp-NZ1%(kut-a4X3Tv)=T#I9+uI=j91irdy?wQt4g
z6CJOqn2XEwe~p?mZfs*2Gxo8mBz1cWK=SjPqP{=195f4*Kes|-Xyij=72Xh+(L4;F
zyJlS)Gw`InGepIaUn|THj4Tn8X`o5|z?%Ji&%uOBhJ?`IYF-)_3rm{H7%(^w*$h}@
zL1w?^du-Q3Z9#GBmS)ti_0Vrwxi-#?l@u0LpFg}#ikuUoEt`@sVSOonkI-UP?b&M6
zTbC(B`_H3YZ&&7ghMi|uqAObS&q<)kx5jSPzqj254fgN!ti=e85${Qyt1x}nMo(`7
z!O|6cp7HOkUT(*gYj;%#zA`+2i2Da4{-e*DQ~XEFlWH^PqVThcXUq$hK4j@=i)?yY
zcax$g{h|VIcKDc<S<!#Kt&)v5({Ot$#*T&+57%|iP?U-#iBbj`=ofWcsd}XLcEy8`
zZ@-=_3iOMZ3OCw|u-<SfB30v?Cx3-+1lH?+waUvbC{!pZNXFtc$0lF8Z2ge;H9xNu
zH~7GKs6?O%Cb~;__L9%|S&_~20v%jZGWF5NyS<!JOug4A5n@B)n)Zh<DzHn!iunpm
z>?k!Z_L68jsZ%c~Dx?vndve2}gEv6tsSUe!ich4<WY6jnD_{OsdY7Y}Ll+m$2@?2p
zsP2#H7#Y%9M`7}WbkD`!E)h985jdQ<K%*tk`H3`O9VXTcm{Y+!spXfHNt!9HPMkPK
z{N+O2-9<ooDqlw>T}@25O*(4#T8zvc>cNnr`~lZ%m|7Y?#B+8`@mq;(abGY-O#Vw6
zgNwuaPaQK?A$kz+yQ8}&?5}&OJIL?;CK``883%m~7nEY*2}{bXVMI4x===nEw6!n6
zO<;zdN`g$}%*)&-y|W8%o_gw2d%dyqIz+Ehuj4?ye9NXM)yQIag832TE!_cyTghNh
znb!_K{Fk9P)s*gPQ|<Ni&n_C^KKHVM{*UmtvC)#MfoW@n^fgzX^n5TU>4}OyQ&QLs
zbr6dqVGFf18<TLvW~Ilh(F-SaBI>Qj<JMEm%HCZO)x=0c;Y`lD5k5EPjIH{5qaTg_
z8ex=^`7vjT3z{;t&|6$52(?Hj8`&3@syT~}3;CTqQN@72#rmnb95>7fw!QR~ADdVy
zQ5+x2u`t2=7w$d$*)I7zx9i50yAya%Pyc{5*_fI_+?TT{&i$yZssh(h<Na9|7b>rO
zBI>@hn}6rP8eY2@xb2)L@hM$3b1X&LYGNar*q*W&&nX;-R_(L9CQ=<dvp?q$8OG*`
z%+3^p)J86bMtqtH?M~PNck28Y%&DLFutoK}*<S4H;*_9rd#IpY|1|Xy+mgLFlfLyr
zyKoW2%%)h2){Teeh5a`c4msMq)V(`5Nt5|ERlge}6=+I~imiKQQ!amtb}mJitvS~|
zk!xM6yTWAHp}Pg+9^E$DV8BZXkc8VrWpf6JxVdBw%UZ6DjUlRJFo{Q3p`moGrQl#v
z%aO$SqDKvx<3%)@vmdgohe=7Mp5d1$bPcUEi~m@-tsQ{y#JjWsrc<^z!sw%wC4`}7
zF9!m8uJ)GRx^-pK@gY_A($-fI*>fVU*YOb(L+Ny*3)_N-v4OKuPp%+%gE2Zw?g8y6
z8rwxyEkl_I+GxGAAi?N%-dD)_-u;f@*oJ5O+kx9_uUkw!rmxX?d?fr{T{fyA^bWS<
zKyS@)jOLp-(w$Til8xQ!uaGwKUK8L_TMb6O$JtlX<=rexU49blD-4U1R}w&GUP45#
zzL2G(Rc)D3Pw%NLsnmX<vvoR}nom-Icb>3t_klv|xtxQoez2he^jDPI|9H4N|64Jt
zA8oP{;=gC!ucSu9yBTSP2w7cay1emn<!ArZ*9LWKMpyObeRyl#3#6XGI?60V4rX7s
z1n|^$)}^H0Iqb%tuL+ouI^6yIF$%qMFsSwVWy065%fZbHQ<%VyAV_F$$or&hTGA;d
z&+erDOP^}nN(cPykHX5Dohuz`+mh6Jv{KWffEnqgaF7iT(5|>)%VoVv`D9X2_Q?h9
ztIyT-oh40ZJ3I<4!iBiczPzstud~}Wc2TiDWWuo#zDFL;`np6B)otYnYWoZg25_lf
zprD+!V|Aj0z1a(wsw2E){4L@@s;5k`QgVr5p@Q?fXbM=m)Z^foaQ#8L#XIA~{FXlD
zj_T(NistY91o+3$`SKyMzie2$Zhv{+YPWCvjbiyW+DH#!oB3<-&5IlbuX*v<ZmaW=
z@3-2LybD;{^yDaBO|2ae)E=)meervPT6dYkQ`WPHoi?GW4!sG~0^^wrpQqztEGv9?
z?e=%!<@aMj><;|a9xR@kSzq+K>ZjyRyuP6=gN>)9gl5GhL@y84#+8>xW_;^smyQWZ
zfHlbVusrp#F=W7JH07t)<&{;vth%~(82;`{;6^RaW}NZon52O$siGez-*xH??FHG4
zVj^6law*zqp5^9LWgxI&siuk|5#p3jzSh1Q(e0Z7GhVo+@fdN_QjS3et*IM#uX7Rr
zt05~~AAfdkhNspKIS$;>R@ij3CEf6m(~T*5KP%QF8`HqWdKnIrqrH1X9!=*>Q*90E
z)LE-E4g!El@7}UXq4j2X*Xa;kV*R@qQqFnKo_Ib^G(tS;6SpWKb6CUxhrK;!h_3>J
zGFc*E*8~UEv%60w4?ap<_lFNHj#H+6Vzha?AsT1MTqG}%ccuX^GoV&v%dmGsSH&R1
zbSoM9`tc$a`h~_<-$jgIcEZCvbM1<x9Ix;M-E`w51$ye#Dv4i^U)3Xv!^}F?Y@$O0
zqUyu1PT_aI=;*h2(9u3lE<9Z|O`*90%3^X9aF=g?*^!kFBH6!e&r^SANMm$>=;N8S
z)49Zos**02pc3pTT_5iz=#&jmiD<44X~D2<7{Rz#wyVi`aSifjsvMk~4@jwL53EjL
zm~PT44ZciaE2Xfu+t4w>kD0l0THB?(jM-tTk%6`Mo^$ZXH<6aIqiwGl6jGf4h270i
zfl)N=SET>SKX>rw_gK&D)wNw6b>X8gAxAI0_&u{{d{ZM%j?m2P2v$T}T%@3)UyZ!R
zZZ`A73h(Z(BAB8*(){-Zk-4wph-RHZnay5>x+@>rRE3*W#CN#)o3}I6pBKM%vi!PO
zh!49dqQV>edyb^9D6gKp66)>muICo^@+oQS`INNezP*S<i70xi{|f>Av<ZQ4U8ZQ&
z$He<P#<bZm_Z2M8S7mD-@V_F6Yyb7c`g9z(qed>o`MeEG<F4&+$X)SH;(R7H@@xAp
z<7bw7vD2{YA=DlVb-4@&ZI#fL!!st|@q)>h@n@5>S*T7Up(t!k3Cld@BmhmeMhk$*
z#QykG07QAET#1f@alYc4I^z=m#38aEJF63TsatTXrO6skr~93nTP-O6Rb`CUp0sid
z*xG;6==tWmB}xwyIU0edj_&G-?+v#Sur~(pTQ`kPW?fhka`h|QS7Js!ieykdk?k4g
zqojk+1&U2YW?TN+E)89h9L=z9QQ@_le4{Qf#)J|{c8|Sr|0-pLmQ40}sV^ouX?DdO
z=5ENnSzH}!+K;HjypRat5#n`QjU}9hypcb&t67&e=}zuqqt~r3l^@L&`z!-){^gpY
zkwjxpwDb1yvbT2sbLU~>LW53*O0v`>XzQLjDIHKVsb_SCDS!_R=Y#SY@JR>SdwKAo
z5j7Z7-02g@<amP62~2VgK}i84N+Yd&<i^L@gLuW-$DZ%v6&V;5h6G>$0AS!K7+M?(
z6M;fSMEMjH{vFES%ie(o%7;cJ!>>s@ApjVL5BlfgBl6MweFK9-u_&^&|IZGFhLYLA
zumIT_9DpVFUBjM2U@^&*7D8+YG@9H7m8^g5EC?g_h(RNcTLTCfl57nIkYxfzp~&oD
z2=wvnph)Duu;72n07asqWQHgx85t-F0X?2F6oo_{Ck;iRkBa=?rG}yb;J*lhfA-NZ
z6d4!|$B>ahBN6`v{u_%T&kl_t_lJQ3u;XNo6ayYf?$7m)7@$X3GS*lqiVTcJ0AvKQ
zSorbE07vN^j{!j8h=18#`zJ5}MFPjG06>pYK1L9LVqwSC1OSMCJN%D7;7IW=tj>ZM
z>~Rk;82Y$!02m4&qY1;3)f<2#;AGL^Xe3z-IQCzP{XYr=5OC!2njJC69IrQkK*7k!
zAkgGwkWlP#K>$cN^1rZu6b2wMWZef)0PJ{E0Tdh{Yaj|mrX~P|CMS&s$X*`+4Tphb
z4Lrh<l?wwU&lrOsZ$1WzAoGVoleZXqG}QjL?cjeDfkmRpGR9)y$F%^19_jO#W?)b_
zaJ=s@1c3QJSRXHIXE%E<8aX*WX+!5g`=g1=CvD&%?cu|BRMS6mU7hG~G}n(hcJy#G
ZpS^voy?p+j&M*WVfu<1>QqfhV`5(sNifI4<

delta 6474
zcmZu!by!v3(w6R&=FsIK<n%d|APo|NGzgM{bO=ao1CVZ{5v3a`=?+PY5NQyQ5)dgt
z_>RB(eD}MT^Q}Mjv-a$ndDpx%v*y{;gLo5tcvaDO05Ty+w*57ydrxiI*xguE8-(D{
z>MaScw-r~1ub(E1zk{9k;o44${#uf*r2fW+wL-@_PuIe^<efovwMX%~OXs=hi_^n{
zj1+Ay>X#Njex$rKzo^b#R5@#8`?bq=e&(372tGI4Mg;wKSgSD{U98-p1|Ci<khEUx
z06X3QFh2`i3AK>><@L5kZC%=EIcX1-u#B?0-Pkq90Z}n0s!d|eFcPtMI$wL`JjTyO
zLW7`5OVXU`&lFu*{5`U}y&KeU(Gi7TOq*C^le;HXo)G!9(59^4wYmU=xbSOe>ms=*
zea$&hY;j}OIj^Pd>$Y63SKdA6@~i53URBo-fFGT2KIuoT(wyhb%-vkZN}X5KlbocT
zzmlGN-l1~1`h>_)Yb@GnVJ2z0wfjgiYuKTQ?rg1q?S9rLhL(I~<itYa)nV1#?5Bn$
zwA+~(5wH1@1M9(AD1X9>sbXb?cME}1kLn-T*~y}N%OpKtF4kJ-zVV@N7a7f@ZGzxQ
z_ye!|>8UcaJkGaACzA;b%V4Z)TEm=wjRlPZzOJXIO}*EI1}_jARWE)c(q}U=82v-y
zJ?MM_53+f5Y#ql(VC+LmKPk+qD3|e}_s9J+QyOMAF?!xgxq(fLlB43_oqAO4v)$i?
zv)zWxr`q<a-KFiZ;FD4=Z-D&<U!dzTP`Nm6;T>zSZN8=a%DeB?9qqmblT`8@a_dZ;
z8$!|fNgiKCql{_${Jb6@<p=-uMJ6~LYEyLWc%<tKk)@ejVIJMaWS5?=Aqz8iR4nn(
zJ<wQmR|An{OkqK4#a*5c?LSd@4R_hw=(wv;v`KkkU+Q#1A8Q&TY5C}btbsdDwL**O
zJf_3vAW!%qeFZD&Ep3(evXh&tOH@Nv!{a?xR6|SIw`!R0)UZ&cF;@qZyBbm29L{a5
zZi=*6lEppZu`AgPC3;~jg_sBk3YiqGDl+n0?y4}zd(2Ku5ne8}8t2<h&+~?iuCK{1
z-gjgP!H+Up8tFIm?Y82EMFDnBH`=<`nMl%N?-m8KhZ2S}%h!=t8cQ?fhrX*gImV(f
zUHvJj<7zZfFT-zMv!(fSZ&dV?|Ge)25p%Lc76D^Fey24<v!F_;fDhzg<UB;oe%(*m
zPiDGI-fcAPJJo?7s#J#LEU(7rmDk-I^Z8vv*8Rc4u<-HC>GDGk6<~;*S@-w#+m)`q
zMAo!Fo8uq~Qi0FM+dTD{Zjmbc{b-hJZKKna(vah4&vvTZshxNmR!ALa$TRU^J|^nv
zvJeM;?+3D{U(=X+M77Cz_@w!dIN0oA`d44ok!v9o?~qdH(OK~lD(s4cxP|ibbcqEg
z2e*#~6D0&^)2@3snUVs36*w_0S=UJKtI`u!Lh2Apt7%noj68^K+J}-iF$xI~tC_Iw
z3wa}MwJ;Fhaa`7I?I*%r!D<|tAC96_tD_|10te+IiRgp31Yw!+;)8Uzl~@?sM!$0Z
zby(dPgVOo<`f*Ro3fR9hF$LtMaT~gG*PcXsC#oPOI^YC2&gi$8eI^VQt5%Xen%W)O
zq?vU6=5<31&YsAqrANypuUbyJ56`>uIeex!<c}<!Ea;PPV*Ep@gI5b9P+ps(uYA;2
z(Pls1-5h&7k1$tTqNY~w|GuA1v>cA<O+$gMHt;3GqCT`Sm+pzEG_5Oku||Tx%Wbjl
za$809eS3^RW-En|;}0fLHUdseIIA(pAlLj$Qyj*KbZ)9I-1b&kN3kyC#@B68vIy>L
zZWkx5W(2HM0?tQCT+r!npy~4WZ#KbCvJdg=hX*<AR{Bo-1M7VFtSh`z^FGHfN$WVX
za7?*fq;YZvrVe=OTIbmI5lRb_n63vZcf66?67^C6TJB!SxMAkju%4*WJt}_N+P$<T
zg^<@Gj&+|hiot(A!{oi&Q*f0MilWvn&6qV3BmKMT*Inne+qN*M9lxsklg!-y+Craa
zWD(8vok|=`{{5l@*G*{-q)c)i&kuk-I74k8;k}PZd)A2fvCOa$i}LhCcmmHFZ!O!=
zQ5JCq0rwiV80z|*dH6G#L!!uJALyqpiYs+IQC<dY>|8aHHXpA~GTSQ{{4tHJ?c}^L
z&CAZe7+3sQbx1mRc=$+7c==;2yO?_GEuCG9TTOQ-34Kx8Q{49UdIq}|cbt#cRSmbA
zm`m=FpP5qBT2dUnWpd~)7<Lu=6b@JO(urYUng#Uoe=n0a1|>}<xRi}%fJ;F^`I;m1
zkg)GA4JGxXYH6AD_$BTxLi~bY!bEw>tUpPWBe&8h^@RlAEr-(%eA)XV#7D2#6N)PA
zuoGK(?N0zRRA>o2XAP{Iko-m=$y1T;odw5FS!nTmvL8P_VG(DMnBrrTNImn;=t172
z5)+_O6Y{Di?cmEXvxpe49>+3)V*$TIuDV6q*_tfX5wW}+=xSjprHsXTu#d7Qb=YLV
zu}yAzd+j4lx|j?%YIy(8(LLpnpp}_Ke`|=;>HxrYC7|`wGa4OM8QU?_gR{X+^#yPc
zM`Chot_*jzP(VaCElcZ>r7AnG!`vh9tP!9Z*|>OfQI#j~1B8WZHdBf7i7KklA?R#0
zecveLMc;{!?w!Y*Ma$`qDY1O<L`@Hj{c_E$auM0;PK+y48Gb`LJuHUK6FL|5*+p(r
zp(2}yNS|p*V7Ez!Fg?93=%)sWqBoJVN`_au$6&e4pM%qvhW8Z=cz8rW@Kx;(Io3er
z&@{+Wn*H>c*fMY7Wx~L3gF$DuF>AH6&l4H(3XWhYxS0MiS#q5Z89|y<bYgQAv$y_2
znAud?x)&=ofdVnyk$2Uu-$UkPsWV+YS0~uuYLv4&K^I3a`!yb+d3fD>&VWBFC7(k!
zH3pg-;GNv`ZeXI<41RM9CqpXTn?8U#s;OOs+ZFWvPxQ0E;hRwR0EauG(B~bi^3*pt
z9ujgft~L`eBIY=*EzZv<?q<$k@NAeeF?d)KEO8C_M<nYKw%vr%Tr5O@>qwG46kFx;
zK~D_RuZ?78JOvF&k0Zx7i$S83jwK7p!irLB1+PPT>oDa8g#(YSmkVSl+{_20SMlmb
zz{ec7qcABYwbls+U!zZFlD!Gdi{)!Qy@iFRdy*r3J#S9OIWN}|nwJ*Udb$Xkc&)1n
zC30-ivcEJBawlP8*&=-jc2^G6rM!0hUK3gRBS0EPX~Q<nx7)lldJAk({>nqr+_7k(
zE_BsyRO{vn%%Yr!N;W@BE!qcQ_AP()X>_W%h#`1V80I$RH+<~K$k<|_<8a?t$<&o`
zY%01Z>n91=rA7a7r!Mh)I3n!174k04A5)@-V|;rRkdgAI<y}4J<xeHs;(QHLR}DH1
zEOjpoZVG6G_=GsPFgh^`R?Z6>9cJ9+2^bqpsBhtE*2n)e>rYfCNeCJQJ{A99EEBXu
zDilW+vGAM0MR!OLr-W2P>ZGQNRJR&sZ`Y`{*wG!4Z0HN@h33z26&dr-RVAGgAR~L&
zUw8mHe`l)hb=omU-3}@Rth%RaizWDo<N;Ior0CMQoD7%1|EaGODRfaONR(7aU?-{Q
zbBLz>XP`>dWgjsu`){cD@wtPlsPVbvQnT{Ig71vqo<xq_&G_7Cc!jHC%h%rYpIMno
zy+*n!_tN)GN8EC^p+bI#xm;ES6|uO7ZRseuDe*cJ3#A=-j1#zu89P`LC8XX}X^;+S
zH5uKL274%<emaQy<>#%I_B|)d38<A=H+e!@v|3>sRX68Dx?3;Um!yl?Ho+61w)G&-
z4>gl}9h#}zlQ(L{Wb${SbyX-|j}%Ql#-|S^{^%P)+r}_TQN;W0emXCgA9ELLLU5i$
zOl*D97p!nNAhSnE=AXg4#sAc)trmKfsff1+(eZ2FoOU#hU-8{$0Wdg=owf-d-1%dA
z`N!_$M9|h;p;vm9jjtxZ^F}UQd)TfEU#;uPX&fzmvOfsFgfwf(V~+oqQO=KE{G|tE
z>Qf+c57~j<r_*`%FTY!LM)QD7lrU^`6rfr9qGuv+B1;HXjlyd0PtkWTRI=nS9EG$E
zu_ul931l2FP|uY$2>~CD+gMf1i}2|M+AEX3(k4J6-=@x;x=zt1RIz?=`a&&=4&iSR
zgpY00OfnmwQut%=BB&o=0tQBOD4$m|P|knJC>cZbFjwVIfXW6}`iIBnr}Klm3FlKL
z-zR1kEafep!%f<g+~OCkydJZ@+`<1<6kgt{K%NW_A^Hg=t_AM6-xvlPKI2LHCPG8e
z6Drrzu6XYwiZbKiN$G{XTGDT}P9i%&*tSEQi^~jHLn7+~VpfByGZD=b%`D~edyt|n
zsHVNxy`kjhfiqe1et<)8HyM8q58GAdu+3(w(4+4JGY99RlTUu<ifym^u$L75s?s+P
z$>*wTaM7`EO#%TRF7p6+cZ1S2K>VqbyFCT3^L3WF-SDiD*Dt)R)kZapmDWU@=WatN
zg=lF@`-|)8CzPk|l}}8aXl4I;_q?za*{aOr_A{tt9Z5}r_hW)DQ$5RQV`zb^a{SlN
zQR<&8>;(jbu8axSpX~-!n>nuB{&=?{d7N$wqJc857rC7V=s-e(^}s&reil6q2F?_v
z@3ex-{FcFWI?>uz<|5Jcpd0H&nq3HF#`v*xV_ix0-fN$(G1AZAZe?Upd{=HAQ#@_;
z+`DM0820gF(R@QkD&n@#`<|%f8*>K8pv3j}rM-_Jd@QV*%h|IANOQaW6O%tV%TELN
zja!O2(4~7oMrPY@hTgIXtB0`%ErPry-l-i<98yz%zz@q_MD}-!Ng9jOh8W*uWA3iS
zXgRy(%Z&+yFwAd@bPuTH39>>Xl#RZ8e0Q+9c+%TUGvChI2ArNhf4fr|>f>73=6})s
zK&*8wa+T!=q5%GVTq;uIvDf`<;Cw}(eAF}e2`f)5V7afr#KgWWrBHwlnYeY^l9`U;
z^PEY}&7SB^c2RF{7NO*vuCsfrDrjd~K9=BG(nkZQqe8MkfQ0nL+NO_dTQeu;#r#D;
z!+F2k$>GKypPe9MQ;qcHzHTuhPT62@QjXJQpOcfsaeszo8OI_INzyMU-4u&2i_d9f
z1CI{>070B(;hPO0_KT>HZ{GVIch3)|07}>S3+p;T_R;SBSL<FKZ{2^j{W<hbZhPU{
z$89~h#P*4D1j!k!%Jo7hDns|wS5aOwYv)zSde{+-`&K|%G{vyDjeF>P5-l6uE^)cE
zv{boGw?FXifpt04lX<mP#eS4vwD@PTI)-Dd2SCUIz%Xy@c)$y|qmkYH)?f~C{*y?l
zV%C=jse$zobjPz}6fcoFxrt=WiN6=-MPfE$og$BWPaOM*wDQ@cswGmd&fG6Z$!Amy
zP<`lRWOsaaf2dkW*KdlBW4F1OStV2GE8o8Eu2eB|uuvyT?IY)OS!~eW_OGrWd(rgA
znt<-%ha>qn;XFYj5S8KCy#+movK^Zv8jEr!z2EttOv|q+Tadw?1wy0hc1KQ2Mx$YR
zG&Z6J^K89q5#yO>YF&Y8eTjRD-_BG65{xJwnC#ue{}H)z4CT$36;p9qAK&L|Hyo8~
z;?+Yon4TUv>Z^}0XcWR4MVWuakoHPV3Ik<1RFBvkiKi{a?G?1loWE(xINz@lI85hC
zQPo_=cVT_4b4Gn%skPta(-xzF)oB*K3k&6*OSyBqUWb?h1R^uWMuGR1a=@DG_|TJR
z26FGyJ-rQ{teh8aW$RLGde~3#FPEJ{9f(b>f)HP@|Mz%k${35Y++24?x1ojOIH2Oi
z>f^dRGd1SeP_+)KXOoWtuDmi&C8-jqUyd~0E+lWT-8HNBL=<3gOGwi5QH4io#o0YW
zby2%>s6y3xM}A3UjnO^HM$j$1`!^*ynn~|~tRq6_7iIFTP#yHdZl7n|v0{=hG>XFM
zo6nkdbShsA2?mpCDZKUUCtCLcGDW$r5D(f36E_Byi#nXkewMR+E!`;B`qL(8a^k8T
z-5YPM;unl`A7<WCMogTdsyYOvDkwKNs(x`UQlF_`H)KgsDWFk3fYc0LciYx@lydS|
z6;_!;p3=KN0_S~KwShmADt=H)6mP?-lRi>EmdvCWM?@J^Z?@sZEfU8447eCD3SXhH
zlcV2LsO=GNe6NSKI_{J;pHy-rqO&pU2s??7kR<0FkhXJO_35;$W{tOf$CkTY?f#mw
zQI64aHN~RAxB2fh<A2^b6wA-tg|8nRz6}Xa*kE0s=<$o3+L9^D+2;5$|Fe91+xU}E
zNmwhGWx1UPBcoR`x0MZ)tqE0WnvQr)i=VdY-{wTXK8~1xX&5p#z$;-oiyzw{pB>e8
zq(3>uWOLrI9Mi5GP2_ZY$*FgJw_aS4Gvu@`q<t$-Ky0PJb4r&<Fl$IX65UFjmV|!i
zQ!pc9tAx@PXZOxLvrcWSgW=VN(p3dzg5z&lYidl<yWguhALN$rF&7#68NAgM!g7#Q
zPfwp#3-DC$+s)=)l!*@ixWG&8+YBVPb+PgE^02jZ{=0LvdO!|^aYMNOZV(t0rpAMD
z1^dv}CaCGr)gvMCv-NQ0M#F2sCVGT;h{Pas0X%eKp1J%DG?-jm0qe%g!PQ04(#w|n
znxZ5O0z*P!5CjwogF!GN5SS1IA_V5XapQlXd_8RK$RXTlWFo(XxIG*NhjK&yE^ZfY
z@_#lk7*aw4NA~~eq0w+0J+uS@M}~nS6Pqn02w)QE#3Ks<0ER~4>Y#8i;ZPWke>fbC
zzHAGTfMalEXxz9UP|QEE0{<B-R04Au7=naDFM~jkNC@&02n312ApnAcVZHx1p%4@t
z`JaJc@v#eqz+oAJl7L=j4}!*;Uv`LwVsH+Fh9huo5olaJ6!8Bz#6T~X0R#g@VXN}*
z`gdtSFbFsfTNn%q$5sLc#Q~N;!~ew$@E;B(FzCx5PzV%pnL;Q84!z6*6q^%V85(xE
zwy>S>-~Rsc4}~I8mvan-VlbBr3EN6I1&8(bw_pE@87K^mLq8M_gX0_qjzj`DAaFG7
za_*oADDpCePy`HpnSLk&0mC^A0*QMV1m=G`6Zm&Np-3na#~6visRbw!o6yS<W7Tld
zghJrd78HfNbZ9L9P?Q8tJ3-O7{SHN=AUJHHF}M+9V7Rq_fg^D01B1k1Y%WJ40fFJr
zDgj61L@a@V<J61<27Va?n{^3jB84pof#ep~b#?XP#(Lt`<rY_SvBO^E*i2(zuotqY
Xm!*f-Ki4q~jzL1m1q76|mC64H+}WnP

diff --git a/docs/my_table_pancancer.pdf b/docs/my_table_pancancer.pdf
index 63d13792f796fccdc5ebef2728e2d04df8c3b7bf..b5349897173d30ff31a1c0dfb33e6412f7c72d8c 100644
GIT binary patch
delta 9456
zcmZvAbzGFs*S4gDG}0j5vB9#tfFL1K(ji^a4GXLwEGZx%%}RGEpwbOe(hbsG3erfa
zFMi+O^LxJ!yz|%GXXeaxu4~Sm&&>UL4kL02<3kJvO0p$~DHJby_}5_=Q5O>yAp>rx
zm-zz+(`TH3jJAyQc~px@iC{gVSaJTV|K$?iMQsI`LtC*oLeONs{^$^8EQvZ_TcB=F
z)}^i)t=Vib3|rni`)Rk-zId>=7)0}9dGQ@#w6mlU+7vx`wg^4?W5;n2qKf)+xw7I+
zUE?H!TA~KbH`J<S900gE(BrH$yr1<qEakkx@s)u7oU|+{dK^Lx{;NzGy*%PB97&q(
zx0*py%I?{fBE9F!^L@(=%eyY$t0Q;KCSQ~WyNw#UY*ejw`4r#t!#Bk4+umHB=M&#+
zA^ed&@M~@1G1q2;E;Y3@Eoa>)8{0DSWpT~P_(;rqhRwA|@vCeId%mgMOjfTH8zXM&
z5i-(HDqMeyg>SXOuk5WKKM6n5EK#&`>-ng4AuS8PHAucx^;37<8SS?&{H~_suJnRb
zc0a%RWi+M6=UH?-B0fAb-6`@FSNt(1J4)6g-;=y<SXQTZ+V%@>ALW##@Yr5^{PDDH
zSKAPBJq_MNX??x!TOBJ)ek@h8!^WPXDbDgkn+iByM2PIWkhsZ&3xzdlvf`MEF_H`&
zP&QdxczjNp^3@I^mwyL0StD5|G-Hfbz_-pWHntBZUF#YLkD?32H+;#36Ih2jJKx@L
z|2;hZ)CFm3(XSxFg`b&jEMbr~9~*?xR!Vl2cf}hoAvu6ORQX9UqcS00Av4`7Mh#q+
zKFVdw`FDgS`pc=Qc9Skx;o?g8=+Y{!#_65wyBMbBy>Tk<m}MsQ6u6OGQgmIhUjm+h
z;T1*Z%i1+=Rc_*z)~M4}J5<Dezl(KR^abkoSSPirkdrS5uB7-cgSo|*7b`2}?U~pu
zz^keK;~{FVOk?rpu&4Dg`oK1l@tAmMDk~8C{fN$i%||f<R$cv^dj;8~!*(NaX^qq5
zA!=hZd%-kBQr4Q|ikg)N{CE_ybt>`KPB}zf&543VAHia&Il3usC;-zK>AXYW$2cDQ
zCh+`3YKgZ}%6`93*^B%z*+jFqTsFb0NT-0-Jky~f4xbo6W88O;Vt)}w1L<qM7ax*i
z<M{#-AIF(*=b4+#mI^{Y@&%AS8@_Ab2Ct*Eadfj<Q*5=f`XzOk5zmL=Oq;mY$JE!8
z@4rIaCKB4*XPX?$hr)On5?;De5vl)CtVcO!*rX>jmM<WS_Nke{H*T(E%y(_>w3@n@
zy}*28>HaiBd}QR3OU%~#n#P^i79-v|=c;mL*ppN}eN{(_Ss$h1W0eAWzA&ZftJD2b
zJ8QU)3OZ2cvvt|&wYBD06lPB=ef#sH6`Hu85TBx6D_!2eV+<8U+kT&9VY{^6vck!p
zW>do_`I|~!X}y`!aw><k4Yy6M-TeC*HpBf<+SHQkff6JCpJ3eh^uB?5#|kIx-^9Q5
zteXC=bhmxKm2v}5u=?9+X??|4o3aMH<P;BkmbWsdgQfQeoq~l=)GDT#p=-f)Ve^iB
zqc(P&U3V;aQFT+atJ1x+WRy69I0bv3(em)zfTM{x<)P~?4x2eu#F>_5Bq5J=W!PEc
zIOsqiAuuW_0idefRTJYTSBRb@cLD=BHQKh&RihU%K*78;GA7&t3IWB)@B}dKASERk
zNZ@)n3?r9A&a|sG1|&yRK_|{H<Bg8g0*DfPK!psPSt$;3Vvms%DY9{~S>`6;?r;zp
zWt-82u!HZTrIL0{1I)BiR!@88t-baZ{du#qvPkoO*`BSR5A7Lm1f6$a^KCFDxHA_#
z;)6%>u`<1JN%+L<SonvbxqmwLo_xlu!`d~cwa{3SyW9u{UERwow9i7W$?+FwKs&?F
z928=P_I@1~(;ND+o^qgYT2Lv|xme(1dD){J&hV;-xo&(4@x4tzvp9cE0*nOS-+f<@
z1d)RF8=|MI8Z=D7{0pi(5`brayiXo-*@t3q31_BOK8XALzMT#R^}v>cq#!>a<Knj~
z8T+%}azqANWQ{$~mzA3gtYZ$@pC?CKGoea!Dmr@WT2_Ra<s=Q`@yFczmS~`DA#N`z
zpZA&CbgeeVe2uaoqsM+mDsg1rL8Z}pp>?3iYN7aSH^}oBIg*Lz%bjDzn2f*^O<m#1
zcy~8aH0znGU*s>O_#2!CY}3S`iM5&r4$QfR1AS$3W8l?lb!4(TNKY)=2<_33$$?6E
zlMRPxywIgBigX|~Cm<UiFY0=cl(u6kwG_D7y(Q0IWWk^fQ|MT#8KiLI<qtYGeEMcS
z_E{Egt-J)u5plR3ug4l|z8w*(m@w^uK2J=nSz+wU&$BAzm(xnxIQ;CPizE{o@^W%#
zfryFMdO1xlm@0gL)Kj>C<$!!p;R4G0!JD+p<%sGBe$X=N=)R1H8JCzD4P)IcK9I*V
zu2FWU{j1aA)2VNsUKc2r?-&n$Ts3}R6A#VB-)9cgeD?ASi<<5;0$JJT!7|S|1fbv7
zS(swNR5;SApDp`4<H@PutVpSS&zqa?6|$YykLBMOB7h3ioPAL;X0*!iVIo~Y)j>8&
zY+jzwj78IZD!_G1jizc?krGhF03e2VhGzNbjRN=a{6g7E7WvLK;uO>LR{1mcG>VZM
zYI?h8`h3IGfWQxmg51YlP62rE7;=JHI(+Su=l!Ny0w+iMPm+gl{@9x)belCSGHQUf
zfwqu!Z2LE_9(A<IUZT}YB^s<zxX~ITvc{`LxDf@7S`A$v%Jf4SqCDBmKUJP?z5GCM
zYQ)mnEvvUV92PM=l9Z;^y)S%^$=_bX^s99@JH@_GZoSv^GDaW~-q(UPD+6u$_1G>=
zV%)o5N8FxYxx7nD;_wz-V8*6Oawq(?n?j<XFFPJkTr@QiX}wA(SD7Dfhf>Q$V%On$
zGnmKucD}G8V^QxA6!Tt(dA_bne-dq0Ij_qQdOx$@Xl#&Ai;tg4U=#T#IH5cExEviP
z@neu>YQ3G1wXn2Kl*mZ0-XP7r+4HC0pdK-5P#^Yfg_&((wv=19TH;aAX<QG<Le{V2
zb@zCQ9?mM6CHoOd;oxFGC~DZgbjGB$wz_oo)54|g?4D>ddVtuUp~Ugm7IKyU?5@-7
z6AuwF$IBu=>q5r|?z~qc20vpN$2KQ_`IXK-G&lho)SwzyEUJHuoti!1al6DefNYd!
z#>6`dZ&?g>%Ee1;U^@tJSL!8C#Hh@b335|5DBtxLPi?@2SW}Y^e@5vtgxe;3DgGr>
zO#x`+RjDT^s7)}AYNxB;Ajs8o;mvxnwiNr)%^k^Je#nM<{#Lu~J&;vdY(7lbHdd2<
zH_?IGJO9TbL)o}jlr#>spKm>|dIZO9Ffe8?Buj+&$;<B#s(UGt@SPcxGemG8B$1vX
z!8!rX4Dvn<%})2_FYQs45=uk6^&aQ4b2MpI8pG!^lHr%7qg7aMs0K%3c6GjKj_h!V
zM!YVBN<^X=d<lH{`{Q*2Buu0GNDU+B#O`0ne)WmM%uk?6|EvJa5ZN8yVkB#JPLwa4
zPp8v0)~=z-ly}|R@E__fbt{#TqS1&Ri~XTu<i|FlTZ;K`z-k8dk}+FIH1UOQiVnqn
z$3xT8*2=Ci_Ib_unpb%%8MKk|0!VR*Q89MQT3`3tfP?PHBgAO9{31h~K3KOC=ZIN0
z><lNpUMEM7={--u{S|wQke$gBHV(57`{yvf>H=CvGJ0n-yDl(gx;Ls|d{-wNK{ZIH
z#0B4eFIBkEqJDw0eb@2m30C0pLDr)hxq*rTtgLt^R*~UpKg}#d`(wLpwDj|(IV9$L
z&4@+5MbMP~$Sb@3g-9i~bp0!xkfdK@h<m!&h32tMc8%qbNPp)0u~@Zm|NSEMATp%G
zUg50hyti+GW8WZ+XzZ({&-(|;3Wdgd_CK?<S?9&2`QHFh4}w}%nifWyEi0qCY{+SH
zJ%f?k$5-{XkBS~i8ry7ZFKf1w@Fy&H%F|G1uVzQsLc9ysJbb=cM{kP>j10Rnbr2r?
z_UfCgG%OoY9`-EvWMK;PYgr*R2G0C0VBA3t{7#Di>rl|)oUC^Xelykk&1e?EBsfvN
ze_tx-6ani;sf;{z)?{jQz+q{5{Gv1G_dD;<>Z__@p15a-N{X@fd+)DKkL*;E`UqE#
z#h<x7Tke}(=|```)5&^i{%AUHd1b!bx;i5!*^5`%7jz!|eO-dV5_bki@j3k}@1gp`
zKNy5sif`U!|K_&X4;55Pb=B)uq3&O-c@)(M7VO>HHb$LZQrQ5ASL0s8>;|1EZO&_p
z4qOT8sFUP!#mfK#37-{*e=*)AbW2D)>wELZ;k3p)Orut^tYsF*u2PNp>p}O4SHq(Y
zM8CJFkFOR=7w0f6@1e1^kdF8kK|_A-E7wjL`B$)~dO}^A`la@U7aB$-R=>;j{0%g{
z4TaZVzhFb<<tT~J>#jJpoGm|SY4)4dEn@F?#vW#2{x*-NRznCmz%F!I?cA$nB4r?<
zQpY9Pm2SDHPlVWsG8M`A|K9rc3L(D`+a`m9IH}p~cb2@Uu3HLWB3qqd5kPu)4!3i8
zz1nnsHVgTz)Jph<T0m56Yb05B(TTETrJc3c#kCYwUK7gnFm8Zh4u9?G3?4-}<+10`
zgbCAC_x{Ch`HNx-@|V$ELtNtLw&~Ou<P<E!DQBMsQ%9(t;ct_5w#wMlvk1SY$_pdP
zOq$gs`|^I`0k*xxW42_3suUXCN@drB+8Q39-YlZ8Ul{V3g9v)W|Jv7sP8mS)wQ`45
zJzGAa)Kuk!v|?Yw#fbD2E^%G6_t`DddNMPe60!_7DmUFzoZ_ygw{ZhR+{Ir#$#)vX
zsnw7SH{N39+uT7^n!nX0(im$^E7l%#vZC%)piU-SXLrjEf1gk>Hk_hL{py7Q{WmE5
zmwsgW`W?q?#=yN#DPw}x+3AtS#2NYMiZQiUC<V2_GK61sn(=>EO|gFwp7dm?o_9)7
z(lC^^x`1BP=l+nimIc?JWznrJGwx@4L)pK>0P&Jy^Y1VCWqk+bWD|RB^B<IT)-Dq}
zzS#;Zj7nukdDh!nk>k_mj;rRFq$;ywJ>l_4xTC1Z$l+a_t2H>iy;bpRnnn_ZA6=*x
zLma4p+L{7;!~Hbin}xa9hK7ScmRQry^m@1G|C!I-z9irt5gcr^K^1PiK~<b~G)5++
zP*kh=+fP(+JuNd@LMwVE0$}1qvWCFkap&^{ZiMJ68|3D{_8pnyubQPf+BK_~Mw44M
z*9bV#TQ(b7_H3s*qKaKMeCSteTsM>!6UU(Rnk)l9MK~*CH>QHl2IPj}jM@0#`w%sc
z_McXsYcSI46~5J68h|F}C<Pz_nn}O(<hNe<=~oTugugFeU0+jV#^_Hbhc}TcAT#pi
zRfHa=5DOOSvf^7cQ}%2p%44PoJ$CcviIW;g)&yPK2^FnTJh9jBjo^oRifhM;>{1Fz
ztnenv9_GzHjI=SnSh)+$VZK;|Kt&2CZ4;%QYC#G6J954G-4f3>-dOC#XRp_eHQ4VG
z3RN+*eI`_$#wHBS4k*jJKj%D?Mr7z6zTN*YAY8!1Ixni8Cn5VtOAvN%FWzN4KQD(>
zYgxmK)p0@qWxFklzgs$5h%q*HdEU5zZB;Y=_c=ka54Q@)a`hz_Y>FKAN*lgPE}^h}
zXD3Q!mvBPWg}|cs!%CKjC`zh7Vt!{-;~pk8fyi8DH}viqdBBQHRr><gz?C6x?|x6<
zvU~l$;H6n+J{nz_N(&f7x)G#MXtJ(Hj!?I*ak8UMuHONlb8J;)B>s6k%-mmVtO%9Q
z3mjo9+nfoHbY)qOOrc7tQ^%*0U|Wx*9M$`LS2;5L+DGEW53N(cbr07H78%$_L#;7r
z!#D>B*x~4s?WJ8t$uSRfTt8uQEqmGY2QT2UBEaqZEQ(eAURsSKXj`5nFZ?nJu#NJ{
zh1T;rBm%*hKb!r>`H@Zo>@fjN$*$TtN+29ea!>MU)vCPxNb|>x(WLkYTY*}9ef?+k
z9R=?wuqD?K2mm3u>s+M&A}k^%Q}Fu!M{TT9g?MhaMdzLSF5wi9tlr|sPNdx;8Cx8Y
z3?8-;bbS9uzI;x6i^x7cVbaC7X4H$1nJVo#=HN14+)2$&R>E||4u7V}o#Di%8!Y|W
zs_crK$#*mT*-qKi?WoPJ26+cf2l{AS6D3~n+%4A_rsILS(U~!}@lCtPFb`=y;j}r@
zFlSME3XU@_h2jgJsvSNg(^tvivySiZd&$oxA`sfIwi;W*s+-a-AKG~+@ft-;R_h_<
z`Sdh`^y=fG{PR}?*6T>0%VL)3AssL2we+V|C#xI_%ad5H{-jPs$_9aNspyekaWfb#
zt&y$fgpTM=UEV6b!iY#4Cv2;Q(wCuipC3y+%A;~zGG|$Kz*}ej@$5ZBYs5Y;=8#Ky
zBQT)<gHf53F|X9=D6XgnmFEQN`PQrVr=Y=v`OQywp8*^r#8o<okgP~r8@y)b<(JMU
z)K}#n=R)qO`sKO=`gF<S)7qTsXafAr9@(yaf&6GMun7&s%JDaH`f7R1bRi}+;#@_q
ziCve+(!W#1Vv^*z9YrI*JaWQ#QIHx%#i)9*Ae2g4l&B$GG>I;idoR?D>U)<&S?hmP
z?rOo??#=2v@<nGmUD=*LPH?*2aJ01_z96|J&gfMyKd?DQ_}J;UALj)g_e2#WuAOmy
zvGO5fZD6K(uJ_8qV(ANk;Tn?iA~_|MaTVw%{cf<+j_~;VbgylyL36W0^$p^Bx)sH2
z)}_(2l{-VyOTB8pKYeWWLUn)jf!=*to!uAnCYKZzh&&&LvBShS*4<V`S7j(tbm6O1
z!Ee2`OxNCqUOvwHvD0O@gr!u(edd6Hfgd!d6iSxtFPNUQT-loyyh8u(-A_jf8YLK}
z!-30}Rh&GPbU*undCp#%^Bp{2Sp~U5P$um6`T$0zz)Kc=jaalEC2CSbaI|<dRHY^+
zZ)t$+#BNzm`Gc|Lg6GB{ZeX&%?x|Cw-&k>f_h1zu2Cp!ttW72BZqv+FZwO~Ex*$1q
zhV~>&_l?Pm1^$uI=A4KIvz0KZZA*JKa)&rTB^&kFvhhQS<9Z0o>MYL)H<<HNx?SUD
z>e5TROLgXz{%sn!LKI!gX*C3i7pLUXk;}%eTTb@?xfsa8CNC({8XJ7bQ9p6kAF9*M
zoXld_3|JWZF}Yg7+-z&k-KvkQ7njKB+a6!ljxiCDYQk<Lar;UJc&GbjD6qxXy>;`~
z*?HC+8;r>PiJ5sAo<(p%+=!Ca?v+Lg34TpbFzjNnnbV<l1%-rkvW!_y#1rgb{mEhz
zoMFnY6DfHW26Hq2lv7Cc_0hy|rS9rZuq0=i1-T4M7@)bmaAIIDgM>tA@#<=|Z@GKQ
z*`(3$(hhlaF+t*NBAmVNV7Rd+)t#^R{q1J3Sn+_IfQg?EM+yZkEtgdDV+VD!Sb}y=
zo1yc`Br|#<Hk6>tY|r!D0673QCDTaCvca$py$#L&;N*T-?vw6&D+c>pYi#_TU4tv_
z4Z7{^sE4Sd!%(mG`9Ht9hxYs!%ZyvRFWXa1QUspd!L9&fo^}$COPM1aJeNeaaPP6M
zdP)iI?3BF|O0}YXg&nPSII?r<IW;k5hdek^m2C7Ai$awp5tCvASJ&`}3hI5FiF|X>
zbQwI3wc4vxveqPiQ_}nejIl2xJqD|&%bi<%CU`+BB%ht4iv&LAM&frldX8I#Z}D35
zGsNUC%R0Z6876kFoYuU{@goQ=%T4S(Z`4~rZd*4bl_lBLVVQc4ej!!Dteix?k~;aD
zrcjh*!WD%-D-}yp_r{P5-XsGwNy|3pCwGFi>I)H`SLjQ;vs5R%2MG$f_c_tKXKU&a
zP+H&nr?6wz`iy$z)DnJqgPMw*AZ2W#n<s&^F;CT+aZ_@j2G3?eR$}pbOx(1hrL)^1
z1pUmOifec~*wn7+`SJH+8X2MF4~b;nn#1LV=3A(eyE6X1OL>P6$_nieS=!ked=$Ih
zydA6o$Dg7PslJ_P5rDLN-n-mw=Kix>U(z+k=i8`pw?skG5NpE5f>vDF*1SQN5wz{D
z**}9;4^Z(fRW95KwFg*HCM(lxazD}YZc}gKjW5dAFTfmB0rIsmS{s&jcoLqAMkZGc
z4}wrEQ>+akeoyZoO?OpluO2*Q^xlze$#|X3SgaP>3_kEK>98AUgjWjD{;DvS;M?$$
zXRbMrnw&}nf67ijC_YX6{sHmuX}Et_D!R&ApLcuZe!IZ%-HJfs9DdEDAM_gn3gf%4
zI>x@Xb?sI!=uqxC88wir;63<^)Gmc^9eSpswwh^-dM7zKow*?PkJY2@@vu2VmF$ZM
zR@IoMtUpEF{}fl`2xWOfuwB-o@wi^W2%(aPjw!fjS2(kkVqN?}w)AULhpw@gPmaz`
z;MhYemcD@0BFN<hv7B5P4ukdRMCVXP3Vhh!%km)%<i_!+CNQxi5S{7fCSbZn5K5JZ
z>iP1e>dt&k?ijZ=QMe)g`vP~0QY)j`pFGt;b^(c%097jc(^lGMrk!pMH;$~3=O4a%
z>{+epKN`{g-TO_TBV~HTm%+qK=lVD7z0LlSr#WuXg5xRaKQL0&emY)<u#}%p;<0%B
zADH=x33n84fY4f5S$LCw04LTIC;Dm7M^wNehKK88LHlBux(Ki5E3+9X*O{59ctv{B
z2VntNk%6k*^x>b>f%9l#aqPk_dXMf^A3PQ`VMdvy0Gc<vGNkzPL&6VZNdRBy$Hysm
z9$=EuV6xOl*Zp&eQj)Rei2{8NC5nk6@_)n6uK#T?H_vk(n}dv1ymJHN6Olg&${y_&
ztui_!PZS=<BKk~Ltqq<z%tOv$;Vxetl1uLgHpqGIfLItGHp&hWP<Ini+M}l#F?Nvp
zg0{KjM2hZ-xN|5D%28W33U6avdr=sUtdn3z5SqyG(yaP;Z+BUl8_L7knu_VJ?*@pd
z$ON!rzruQtA^$&DC}$dHR8-I3n^O_{Jio_u1%E=|0MI5v1(T~eBmr!P;q^U8If#SJ
z@w0a=G9YQzpT_R{V4r#sQ}>!$3t3UOam)szyZ#Xlo(0#poY<_b^nI{+w^ISuW7aH!
zqmvK6U{8m&^+j96a;<jc<c713dtcKIo3Rat6KMvPHNI(Vh*j}NRgF)2R)|q;owObi
zHOxORbQ#oT%#LMVds#?i62oz7&Q^)9f-(K5=FVq*XR}eRfcfzv?=W8s5M@$~MEyHb
zL^o~H3*5WYBqi^=EC@v%=lQa>WSdULTI~zXj-Biye*lPbexjE$>0Wm@(8x7U!=7_v
zetIOC1wM2oNeq1c8YRK(AXkI@@^or%LgSQU2gnlbZ5O;?2@L}Q0(X(&KVl5<D(Aiw
z1KabXG46Kh(&YB;7PRwV?^X_|v5BM(0x7FbX?OhJm(5!EyIdqPw|Z+~q~jcqpD7OQ
zc1hn4rU{q^Gs!RVh)c&RL}G{;XNWrN<OiHcpW_AnwC9Q>M1`CBHha52Gwj%jW5eyz
zzf@xh<k~d*H1eT}PN2@t4Vo-Bk}iofFP-yN$COj*jHvfSg)y=6e4)c$W`E!-iYuMb
zpgfr`ZyeqDz^~Ru6L-Tvr*vbdJ}<^8b`vg@+mYU|eC)Sqx~Z*N@6U+G*qJ(@%e8pl
zu-b_kM=C6o4TUIUFWg8>YU_>iVekUX=~JV(lj`K{Ut+K90Pm-bnX|o>!g_ic()McM
zn0n~(Xjc+}i<C>#XBm>zsLG!ydx<s2z1!21KT8gz>ZJ8w+Rj@hQzpv0C-}7pMd*}@
zWsz@3w^IsV&=@TWDov?6GxxD<QM_z`&oR&1uBt*TzN5(Qi{fF~7&`pe%X(+mRQKZP
z3|UH^>)}_R3FTf&>6^XiQ$v-z>7tigwtC|8B_T`}pX7~v_b-DcPk{Z@d~bH!eehU+
zEHG>h#UH4CKM+pmIn6DMSpVrU=*u!OF%a;(Qt_2ofD#i_!dq;e7BSXn$ippZq+hap
z2mi?oAzQVY3xS{SdMb1qZ&aWl4N*ZFi%>&ul|rj)2*HLU^jHPz67n)rJO^h^$MvON
z0gLBD8+k0sF|J5vv*Qf4nKiud3GST-i_|<voqw>FIKiO!<>wUfC?<R?2wbEhf+-1(
z2?WHeYp|jqF?~^3z<V-#Wzs}6r0eD16i9biX8%C)($hMC-Ku$^4RvPvM5^EM>E(TL
z`air@z7&#qjcV+})NVbU+`)C$6(?YAwsusAnb!On4fhyHHmjSMOJm>Ru=jd*B~1<~
z2qBTfNOuW9NUP{)0gIk-EjQdbEAihEm`E{ec>Lh`+>iq66qyKDykmq%@)O*0Wzlp-
z!42IE^z)*20|&_EvR2i7^zN&eY`-ARaVJ*`#T_lhhuTO$XT2(6+?%ZJTDQ=R4~qtp
zy(TYw@7O0O#t~RLJ$FaAS(-Wi?Kzv<5kTYp`6(+{o@roV3caXsGcdVJ_JSEI%nV@G
zU>5SWbaQ5gLMpzRYhh!E#0yw+V8G%vt)(SkJOn~A*UKPmot<RO5SGl`vZ5dW2m%BF
zfj~G2A`ImNfVcnvE*@qHiT{B@x>;Hg0GOfB_%UmMHB1=74EWoaotO#!>3|?GAo#ZJ
z|1%E`gWjAc0sz2n+d%MmI~y1_>^ijg0vmP|3;?*M_P<d@0I*xAB4F@s1PB~>(^nV>
z2HmuQule7yfkoigHq`&73%mskfB|mN1;9Yyn*jn~B7mF00AO&?O$h*S0PJ7${^DOZ
zI0$r;9RMyOe3J<P4!y+~0Ege&BOm|(z3B@CfB-jx1_DsvTMGgK5b$4VuG@bT0eDRX
zaMK0^irfqu2!z0H`2yj>w}3&ykbji9=KuddK-VdA69fbkxhWwK3=sa8g#Sc(z3cy$
z^*^@%fczT+ECT+w??3tjg@L#B7$_`!TS8$d{1y{oIP8|x5HRqTG7u5rTgr$4QMZ|h
z2#eeT5fK61a)ts#Zm9(Y!fu`>AQXHnw}4RL{{(~jm;6vD{1yld0J+5k1_6rP+$I<d
zbjt<@0B;^UARPR^xAU+5*ZFZfYB&sdlN|^ExOJRB0LZQE2VE!s&7iNV;Qvjyf8_!Q
z2ogr!OfC>m_|_hSuEV}5E9m;f-ee5AF0(gt;d&bQ76upq`cD!P|2O+VB5(jCzTS~R
y7|JZ9;p~iHzMk^8<SRH?U6=f8tm}{K((R5gb3^=7xIxz$AWXo)@mN)k;Qs)0Y<_<L

delta 8996
zcmZvA2Q(bq(>H?XqC}MFy+pQPcM%bh#bWigMDIO%L~N`Uy{+DRc@SL?JxU1CLUf`_
zv{*q3-{yJW?|c7meD|E)b9Z*;{$_r6X3m@&y+RndKv)w`h(0jWit`~>+75jBmeeXP
zh=eA%SEiO$3Lr)keeY9!{e5(&?qjbV?PTQI(cI#V2M_J+5EWSL5Eg5;*zt20z4XTK
z1b1QAyEPL&zcU|YMq_zKh&H1Qz<*y#zFd{N=#X;{_<3ZGu|TbLx@}!L@*jn2Twa{6
z9-j8@$=o<Ylc=52Uf*D$4c5k}+`;7YRN9!@7Bz!aD0{_*$XOe-YPkA(E`iubyXGc`
z!3jAqNxu<^TL`DZEY77))((~>>gI#NPaL+{GYBEUks$CZcF2;d&7tZFk0J6t?Sa|a
z(@Q;fT9^IOQ`+pT12aw<1r~vpI(vs|`c+w-X(897cp?fDIT=}&iz(JbZ2+%}=0;uu
zP4LK5S$K7x;vHOk@{!j4TP2*s*C<U5i;+O-blj{1oNPFqO8ZOF*C*nEVXaRvPwuuq
zDcuo>$jx<y3WQ<}UEZs-zI*!t34vSjCw(X4L;HCb`_Q+HDe4c+It-EyGtLx4COg9f
zcj_mjd!^TsJvaGuvQ%=jZBYrywN$d9!^cvErfMb|<F=mbOq3D&l>Ak~CrN{$JlfoL
zrJS-=)(XAB41!N#>1VS$aHCJu;>F@sH1|rus2?6PJiMuF(&gCt$r}REHu`y|8Xm-+
z=%eGwk%6=P^30XPuKu(nXC%FxOnX2Bw2k-rHH<OunaYu#!1KTi@*D@7WLXDM!6Z4E
z5oqsfC;J}zDV$d2$1jOvV6~$IsT9_!6sJ-zoMbxleow|xR-{PjEND)F7PKIU0GA98
zP5>bv<LL84d+#5<3m1+37V_Ef*6Z;=^nwdr4$FS@q}Ju#K-qxrU)_IF0?$@wm)FiW
z>r=x!sdLFLb`H&Y>pO4n-;<Gry%k_D(pNhyBuq?#Wby!sE64SZ>}zF=c??hmRJtO>
z{l?>oS#M_PNem{L4?>t_8ta7}i-qU>m_o=47E0f}%TymHwOU5pn);NUtv)WQj)t+u
zIlOe0>Nb3bZCpy<-&NOZ=U4aJyf^bkTd`oM<~@T%&lB0^7gpLec2kM>l+}3NdGGMs
zP9;7j>#LNN9v*y`+%+ViQtPc<`zl*MHT+YuJek;bVf#v!2}J`94D7*gE?Ive<oDrS
z@{8tZ#5bF`jdgALC)e#VA1-e+3=g7{2|9Y->R%Yat3G903n*{DTK_PZEI$@qQgg=}
zo1_|~x7C6x7bV<C(^e9<MOG8b!rh@1I1dkDg1%b&d;gpX@){61Wv*{5J>?&R=Diy%
z?y|OybFC7J2^5-cOFki8OZS<msSz#BP7auicW<&?8pyDa2HfRS+t&8xaruZ=r?sUr
zko7BV-c1>4t+L2c-FsXilhCvqcBgMnY*pdm12(-cwjViSv8kh<bnzB?dqn#8tpKwv
z3zhRyU&7W7YUGA1n;9Jb**9nANV_fH-KW3Uq365FHsXD2U%TG*4xguc-Rs7lS?bgh
z4o4}r^)Mz2aZBI%NQsP$2w)dF4YBXt|2p0S4t*4)8nn{}5YQgAuQ_v6DY3IqE5gvp
zMTMd(K>eXuFv>5$)G_^x3DFHVMx+S}tQjlA3U$<+B5c4w0qySXw8n`a@j&sSEILst
zH9-`XnL*f&Doa?1#~StLplfi|=&tA|+&0mywvv8^VK@Lwxw#j5-JCM>Xat+3PFBLt
ziiIQLL-0G)pF~+(6?y>_Dz+kkV4?YLqTVuzfxXFR9}e!FF;;|NFqow8?+%Bfa+f-X
zt{+Db>PO26ZNAV5()VCC@RQ}(7kczy4vD_q@qRpkiYzDWTkCrDR(L`jiRL!6y884S
zc=|@Eb30+#JPd~3f7D`cr>nT(C+n&v*x5hkPSfPSe&Ei;O*ayi!8bh`Jygi2E^^u*
zqCym<O_ry7VFvHlG50b8&(v-u^c;5C90gjQ26g|KX*+-!$xuP_&lifGr!v~IPj|JH
z^8zZy-xkV41t(o((jJ0UnL|T^T$7UNS&S$*F^oOFs^;jNr)8)SdePI1$oUt{zYR0g
z(sGPR2VRqlW7i6~j7cAYO}9edR&!D=b9G@3)6IID<B6tAzva@i==3;pHhf9#I#zx_
znrDE)F;?cb7S!fuB?WgecE=rCef_!Ca`zKI!9TYvOT62RdCZ?eOrunKM8i54QZ77@
z0#1Srl=ZIY)54H%K#5Yg$brbU<OFIHHEv7>>&Mq05|h})$Wm6$fzm{jyUa>Ak@Vx|
zRcj$x6vJHi3?{97iJ8g>RrzwmpN1<+CQDl;Xg8APuxC)As~86dYbMF$YUhyjKgU(|
zNW}OCS~)AK;-jffNmeUv)+;_+BhJz{m)i40MP|^UNj2I}xJ5lWXgKG-9R7UL>Avv&
zt5FNBVT;Vn+371m4Vitd5z%8mUrW=Gfs)R%C$E3U)B2)OpH_3M^2rS!5DPY+r9I56
zu3;pL8zj5_0fBOz9uB_GwVI6(o3jkP=JXKYA##HjgA&}>*AINe_9N07h}M7Y(AKA9
ziu!1=iEh~<6wfiXs*db8hy(7GaXUHY*-Vbx8oVjnct;qv59@pS%%)Ivg~MWT^>FtT
z(UDk0Z#NAc-fGhpS%T^6%XCar;7FpmDibLw+G~xuOlU$vdYa%0diPks%zCQ7-%O8h
zcv}3H1Pra!EFRDZr{mHZGAuETO2NFJ%?qAKqs#Pj7s0`y+T)6*Yh|QSC9iec`fI9D
z;mk2eUdx(>@7n=26yG0nza3CC+8R5I8XHexDvw=tVAdz7Rtd7mWlvHwf6nr;eK__e
z*C&E-7Yf%Vy--aK3)wz%LjoC8>`TsJky4k4oLGo^Q0T^j0=jMUVItG2x4Fo!x8&OF
zYjhZ$i$ekHln@6}Jd5LcuC>{d93wyF_1fWB(-sz)^SM#pe!$$mXl!q!#%8s{*3F8W
zOmQim0e<pBR`Nd}YAT!>TQ|OZTjfuf95-PPt9D+z6Xn_AdukC?fBPb_(S52<OYw~_
zN^9TwHx2b1r2zVrbT9laXC^M(S$m$O<0ZNzk6SHtHq_MV;{|DdUz6*w|3SFRrGDe;
zd_wi~K@>#%#U%&zT<7Uw8^q!A&9SfBgafbeKirF5M&5wP$EAhDzegTpGU_Q=%vVKY
z2U+<&953VdsHk2=W!}YfJEWM#^s=^YQWUZz*nNTuKNrhgV&xeA@@tU0vzLci7D0zD
z$##1UW5jW7o*<ei+x2N(sb_XG;rSTeZG#~amo@1D7$p(69hu`=&AQWNnO;tfn%~*i
ziAjO{&7g5)_!xzpYg?D#>ac!L!!rDc^<MLr=?$HuofU~B%>H};4@Uz+X+8R;DHjj*
z5p$D9`3J@N)NNOaoTW3s=Jt1CTm%}RVNBw$=<<LRdb$3<M+8@1bIL}7P~3j$md&`f
zmxPR2y16>9AK~?Lq#Q`Evxo{1>HBSbO)j@#sF8-mLK%iMcq8q7o~&!uK!KCUbO8IP
zh3@HY-g7{y>o)8J&t98k)ktkEZFQqo>AMGJPCy;{WlhQO*}V32I%8amV?l52tS2d(
zu_vLx27Lt5WOSBtR;AU+_9@q$A{|Hs=M1^qynh?2FpCAqMdVgFz>WL+jnguY)QWWu
zJ|wqJiX@EoSJise2aj?{pIjtQd_eJ&N{f(%4Fm_f#$;@bki0;4JaW#f|6L;AGQItA
z0!Z?qtK~@XwNBKs$TDaKHI62AI$Vl=^0btxQ$OG4QsVJ2U3a;m^($6Rdum=T<wp$!
z3#{^f3uWD8vQ4LxdyB5^ax+afc2wD#y)A$MS*zWtFW2@snh-^qgW4?7=i9_SyC>D(
z?-aU7z>~U|8?A<Xw}xJ2l7>*=)<|YdZ_0sx4JxphMuz}}V!{DBUeaitZ>{%Ezyr8!
zOHt{i;7-6nc(b#*(>uuw^0|wT;%_OnIrVQZh{ESr8w%Mc_eWcxR+2WQ+GZE%Ti%Q%
zor0CMYh%wtU%9h3l=fQ6JcYEYKRv712>Hddar42&7yp5#UyWnJ7(=fHhRMo<%3q^V
zh*}}XsZD0qQS2KLrCUentWzAepsl1c@G@>%zIgcdv}fIm*3O+hB1x2xdGX-xKNk*5
z;y3!!j5Jb(T#FVe<T<#H_Gf_nix!Cs6X_OIdLh<;njwE6M{~oz)vl;_aYk&LE#aEh
z&XeX~(ao6nNY`PP1(){YZ*95g=f~BrG*wof8=fn4c{JA6Ip1<bf7TNF+>q8y$A12z
ztgA=%a7-K*b=P=5r^Hi^od~DoTf^5Qb!~=CBv0noo{`_y(aebQ&3iokdAU3vM``?V
zxc$S=cbpgzgp`{Vx@$4zc-gP>lNq+qinAI3tvKmU`#s!Qt+Vt8WY_9AJk1YM*8Hsc
z^2g!*FvvmRh-x;Pi`~;)S&r}_l1-w<S&fT>M$To-x`F?`n*XTSEq8@5mi1b$NAUv<
z8Yz)4R4Xs|R6IplTM8(ZdK5p@YpPy640n~2QCif@p&??J`y%3<^!rc?l3JCCWjELs
zY%4P<6D+({q1>019adRH-O0R~YaI<fKc0-C$BHXtHkR(71>WUmyRO)S2MV9*?g}hg
z-#JOz4i&HS7)2_Hrab+~B}x509kn6WSD=X;k{80_M}2`h?NQ`IC#P1x`}sM|&XJv4
zK%W#g!%!a~+GR)N07Iw`$RFmHVu@EW^3Z~{O~fR7`1AYcM^$FkPmViQZt$Zx=!7Z^
zMSr`KgVE0F5HANF4oiJ2!OK;8uQdQ;W#yJ;r&8J<zw~Fs{GN~YPYpVbBkr5LeZ5NK
z5(f}0jmhLg`?Na1>4p2MrZfu7)c6u?U@6jw^swSs`t~U;k*%*@xbX|G?txnr6Au78
zaWf~;rm?xYqvtz9-0{htYRbfhM@7|HRuQJ?U7=)8AL&HwLD6SncNSwl<u*{0G7kUQ
z$jXhC>o<cu<^C8RQ>Z)I8tb3WGrSg*MHBwqwNKoz=rGd3sX@2)Zbo>q51UwBRpLlL
z);*!!<;lEz!iKmia@kpxgn4$Jxs#gNsQNMNc|Gu^wY8g-0vpI<F=E*{q&ACOT?PHK
zq>TjQ)&o!39UPP%$s&T*wcLD6QPeQ3z$KVU^kvK8Bg~k;t|KlrNi-;g(Fn1QL+}wE
zV|ifhj1H_NS*8(uZw9sbN)33(fpv`Uc8Zn5Sd5VG@NzMCnPNqFH8K55HQ|Iw(S#6k
zoyc{ZHeYY7*mZa0D@E2-jR&t3(b{r)lIkFT;W`dAy$AaIb^ddD*%&<@^6=t+PmBFw
z;0P<YxG8GGa6%hK+M1~E-s#{eMIgXm0zM6)sF})6klGdSjoa60SpmG!AWFj~Mn<Ob
zsxC$}=rtErG4MAuBXYw4DtG4&GZ;krw0-e2zdBi18VRQVM1>#;gtjzv$84BXAd9Lh
zY8U(pE1Ll&Y+P|{1WD;ijZ@h&MtiN<!L$`6QG<enYKYj28{PB7f@ujL*$2#Wwt8I?
zIrxDaLq}<Ciu#oS9%I))B0Vh;MOnaV5<m+%J&^Zibd7z+WV}W+rLbLy56PXS*@t}i
zS$%cJb5HTl*pG&*vyCj2g&d?Mc)&e&#0a1B^(%@nTja|6iablh@2-Jw!@F(%m^aW2
z1M+R~e-E+LUPQlyMgS8i;KSJP=ByJ>9v6%%;+MwtI~&n4$C)owmxQ1{W4ic#+aW_o
z^+Rba2sbl%M<&^3TlzswHq}m%asG57LUNgiujp`;wjaEsfCh4d9P2{A5JD#?W|O<U
zOWGX=V`qPl3E_l1G?LoqS#PE+3h4<=)w#o-z}gySI>J}n9z@0;E-llm<8$`Xx_5=B
zdxBaLX(gPv-C)XANlq#BdAH^1lN@9(i6vOxhO}7goQE>o>#JC9f^1vCyM@q}{UgP9
z>*#MQI{l{|f`~nynrfpy7CDO@-s%aZgy&m&6mz^Aa3pVK?^Av@SF$RX-N6toLxh-h
zxdVJ+{-HonKMNvIK*87*D+*Hi`f~t;QF}5-C0S!W>{$$pb~hC3s$=IdoF<u-oV}|6
zwH@M(XAyZ3k~u$rpVe!{*;~-QYF5|yKH7Gfx|uVQx9q-?`5e7z)+d4{u;Hwh59wF_
zCi7myw{SNDB#W}WtD@n2RX}(P5mW|~!r(#-;;#Lq>F*(1Yv@$QBkLFPi`=BjoD1w+
zTIB0TiimG-2y)F1eJsg>aG5miPp|uF!h~cl;hW2!j;zib16-rtU>EG_sJiI+fp!w}
z<-QiSAe7}k571Hw3vB+#NM+8f$qMs``T1ISE`NpKu6Zh(4@-Oa1u`wsc(0%FftUl?
zFIShrR2ySV(<8FD>Vq-J8&`+%qoRY~b>s-7@S|YIm|4fOA5RV^C!Rer{+z^)TI<&h
zJ5gLHpsS*P{ev~C=&NCxDr*{SARH}|U3zWsX8w7=v;3DM_unfn6EHZq#I2txo;JID
z$bz0Lxv0d2w@s9|`sK#jEqs!EWh8Ul!!&A{RG_s<^OiP%FP~?3;HB-35t#|gw?4@C
zihb5+m(wpkNCnbZsxlH4GBNB#2iK2UMGHf;k2%uE)KsJAcWmWcFx{3Ms^nQ{q#eYk
zi35cg8L*>_QDA;cCmo;8QzN)D<{p`rtQlZcdKlzVP*0{*M#vF0oTfHeKKZJuWhSIG
z|3vV!TYT?A`TNpXbf8n09pyTv={lb+Q;Yq&fo}yaVe$@?p;GN|rNNySp#BPU0QK~}
z28Wx69=WRV@91taY@y_D6Q`gb31?5iB!0^@o`+JZm$9k4EkvYmA9c0r#F_amiH%RN
zq(=$Ld?pQ^7@p4K`$}W6?Ij%M)9xRz?(L+|Z%~q_WlJ?A{n2k3LRYZTQy_n)Hkmw!
zlnmT)aXP#q9=&o{1vg1Em6XGEgoZwR4Zsnt%4>oPjAK4LxA&&{<w1lFr?47*(#(;2
z{Ya02mSDO^hX>~e$<v9Oc@Vgym_ldx{6<_%*&RF}$FFSs+{yX&L-<DEsY4en1;ax{
zG3pSd=%ue#c17#UH;#i`rR<*tBj(I0cs^gee7BN?GQXzwV3Mi5p20NQJyym3&P#wL
zpjqPEMc?7}?w-an{*@4oKHlHR^nDfH>}HBS-M3+A9qeDc!{N1%P@nS@3ALDWp89q^
zGgAQDq_e-FsPPuVz(jYWB<_0_emrh`aN~1FNp>Y0t37e=+?Ul)T$^&##DtXTlCqyU
z#&<jdq6i=R^%l)RHT}H~{QYnrZn>E~KMj0++IjyHcQLd2W8{l3db#~~@vO%gMOr>@
zm-bhAc0Txk?R8hHJ6%2i*IPy9qx-EFZyfRgTQ#;^Z#nO>dil(pq&oVYPsS~`KZV3p
zr_ik21+1-;Z4|UVbEEdkPh)*4NcVH@NV2#6-kCb3g*Mz>FxC&2^W|i;G1YDV4SG?L
zS?fIu<*;M<ad~buIT|PZQHK&+mv$YOLU7g$SjfERt-CJg^GMM=Z{}uE7jHs})31;d
zOSS0ft@%EZa)oL`#7pIKbnI}z!0v0z9+zNHN}P!xto<P{H#^@_%u+|}MWZRxH>Jh^
z-QfZzW=GOOwh+;i#PPfGKn0Y)FLQS0`kYon-&b<8MolDK9L<=J?BPS9Kqk<*Zu&eP
zqb<Bul9yb*!FT&D!p6<>8;M$_WE8`;W(NMz(<n=^Q>~Ag=vs3!oxkzeT^*oTZ*F(D
z9IEIWr?`%!w7h95D&0P{{6^Hu`{B7^<FeFp#<v}bMys*Y1;4^o^<qj50Di@>x=Der
z2|n6evFN8wyhZyQNLx>Am83NS3yB_oH%dp&(%u5tGN!7r=?Ezq`Ex&N7fmWFMwJka
zB7vf#>~<zqXFinY^!>vbPIl?>PC1JTotk|C4M3NVegQfIqCN#?C6?QYB2(1|YH!q%
z4Xe^21K;@z&B`q0`c*EM#_OmlYde;+5~#DIHBMexKR|2iC(;vgK!8pk8gwW6-q%%`
zpzDb!^2KygCf<Kb;oJ3j_?dsfeC>&`n`or(UX=|ILrpNiRPWhH#G6F{1Ve#|iHqf-
zk9NI2<Hwirpl?3)4Pg}krj3ywYE9fc`b3R;0_y~HizfyZ%H$1?wiF}D9VYU8Dq`w>
zB0~8c`}WcN9p75#85%8bWlb1_id}atnEv`jkeQ{0$vsQO;MRQxr%m}+D%g{i!NFt#
z{$LS381Vk)I;v}I<oO+uq=W<~LPUMRypSGsgb8_Nm?uM(?PHl!;n-lupk(~~&E)jG
zi=~4jdw}1AKQGj}X3zV;b{!?JMe1vF!elw}RfrnhJCmK9AWGN^^Tf()kB*0;>UDmU
zl6x=X^#~{vkMsBEqfN-yRZfewinD$O)H;<cSmnLzY9zOvG<SX>BmdZBJh4$XONi~J
zOfO(B59+eluU<@Tef_M95Z*259;!H7mPWrpMcZ8tOxWG5p-~{)#FRQ`ksx>zn(`!G
z+o1`4=IF6s1d0?HW*&4=27?ui{QhfrlJH8M5aJE^)TRHa%X`qIpm={l)p16hjEK8{
z-r1CEzRSBNOn7U1;yf!aSICH`GxYk+tYdO4mljAW+}s$7_?j_G&u>-uvjo@kHKaOT
z2$sp8c22k6%M=nF5$lF2{pkueC|E~3V|6|ktI);^v1G19e&bsa6A!?@OGY2)6)CpA
z{qrvBUoTV=tCmN>B5a3EOBzaQF=S>aH-Fn|@kUa>$^`!enuyihuCp@|BFVHGV_GCe
z2H<C<DWc&jS`c+gbVJ1EiscetGojp+zW-oM*KJpNrQdKvnrFxi-}eq9x6r?W*<VG$
zF$KP7qh(ZW2{er4;Ue$Tb$<qC<WV77J7t3Tzxu<+@^C|uusC$@cm%Z$29&L|^jJf%
z3+3q4Hp@<l!@p6mxIjJ$Gi`mLnNhxB-Z~j}_XW|j4!XIJM}*_@%>)Z5H;W0upvAE=
z|Ci4RL5wK`9IgM{z|K(&%c89mzRKt^X|*$W&9@rJkH`3bDGi#T>D_)@#Jp(1s>liG
zzO-K<thZo3w_S_pj~nLM$=)9v0PA`rzWe#2h9$Mn%5|t!Uv<`?W`I~?r<~3|b+K!>
zi>%42V;0za!@ea!$0|&eot-B76~I4vUVWh8M#H4kHOf!U(gT`Pb9U(2&AOqweu7n;
zDEIx7vYzqG>8jhy>#r9L%P=p90MGg<cVt49h(#iR<^!^YYyGAyhIg^F5Wh|zj8we)
z^ww17+Gif!q}%zl({teztFkcKq?oX(kM?VABS(|TT3C+oWJA$rQ|yazZD8rgecJIg
zVt=Epj@$-#ZqARK0daJaw=gD^twfvCZ4MiIo}%{;tSymIyT_Y@K?1R$Qdlz6N-A^U
zuU+lIrAg%`wVd`$!+my0o&xh?AO2QXB`U)JMJn37lo-1@J#<nW;+*jPjI3?ON(5Tk
z2L}X`W_*8UN!`A3XDO;E_|DB5VvC)d9R8o2i`th1iW`a{)F04I9R@M9!|W5ERYmuV
z6AgGqVsJlQj2aw^RS_XFG&*D3ncF{*My-M0g$r&gyy=4Yx4hw2)cc_gZsO3&4+gyG
zAKAR1X|4XAnaR=@D^DDg1YtjZbW}b2<7~+M!-m&*d3{_?a-R;72#z`U(e7^HGH27o
z0KlyBjRWUWIKvb4!L<CPEc>Oyy_^!6zCe>5%k$^i$MVYF&z<tnD1IwgccLsu0M2K~
zbGsznL|91fF{+}LfIgt+7TmcQcll!uQa?rZPBbhFYec3YEhLMZj%u9`WvM1pL$huK
zOJI=^1HNk&^Zq2b#Y<--E9L`p_;n)q0eO~ctg>=UPoT&}6InX#<#p>h;AaXOS8Go%
z4;u@YKRY)|M+zW_3&8bf0|CRJ^;(=MuzDht_O*J0$EMe>``dW9aX}>N`>l0}2_=)*
z9QX+#Ne>(p<RHQncOT-9@p5o;RkZN3;Sy4m1_3~lKoCFz2n2v7p`rkgAOIjJ%q1uH
zf1&(5Y-}k2To9?GZU=xYSQ5wu__MfNxhVeKfF!{{*j3s8M=$At8w0bXBv9gtwj@|G
z$<Pr>41t0mNmxfdGz1Eex~c`eiUXAZ|E(tlfI<G2fu$s%S7Z_rS7HG{p?~zy|0_TV
zDcIk@00>m#Zx8?!&){Dm0H_4uZwCQT2pDih4+{Mcy+8Q)1p|Pt0K+6C{^kz=lZ5?;
z@qgPwfLEM>K_P$J0`b~^>j431;FSaM>2ZZFAV3O+PsBg#|D^*E0F(OLX&?{``<rSY
z5F&8}7zC2~ml=Hg|8pQn0&oQcBnA1KLLlgBE&#!R|D^R_Pl4e72Ki46umt!&8T^-j
zywg|i7$^a{N}+@#>`EjO_yqZz8A;%kLIFxjTqzWwBn*8etASD=sVg8-65uPeN<pQr
zuq6e9{#{K#2=Gd70U`KS@UPS8|DYct1-JqNfl6MvV<;H-cZmV<zFd_-fqz#H5C;6;
z*ZGHkAPjWXYnarZ&i7~iPkz9lSIP+l0AI;|5J2)u#2|dK{+&l4AV3ly|NjO7;o16|
zeh?4>{+m`12;Uk0wgrK&lq?7&DRBiu3g3kP%QmUUjY&d^>#nw&n->>e#-+`5SH;y9
h-_`L>;D6w|v!|DZhu6Qo8J`#s00lq)BMmsk{{clqkDdSk